This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Need for immunization against other single viral diseases
Z21_NEED_IMMUNI_OTH_SINGLE_VIRAL_DISEA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
732 |
4. Check minimum number of eventsNone |
732 |
5. Include endpointsNone |
732 |
6. Filter based on genotype QC (FinnGen only) |
681 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_COMMUNICAB_DISEA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z2
Similar endpoints
↥List of similar endpoints to
Need for immunization against other single viral diseases
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to communicable diseases
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 681 | 282 | 399 |
| Unadjusted period prevalence (%) | 0.15 | 0.10 | 0.18 |
| Median age at first event (years) | 56.44 | 57.26 | 55.87 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 732
- Matched controls
- 7320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z25.1
ICD-10 Finland
Need for immunization against influenza
338.9
307.7
637
142
WW200
NOMESCO Finland
Immunization
450.7
307.7
583
63
Z3231
NOMESCO Finland
Registered nurse
14.4
272.7
557
1323
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
36.6
248.2
161
56
Z49.1
ICD-10 Finland
Extracorporeal dialysis
47.6
222.7
133
34
TK800
NOMESCO Finland
Hemodialysis
29.5
219.7
153
65
Z2221
NOMESCO Finland
Medical doctor
10.1
217.5
497
1265
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
326.2
216.8
210
9
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
29.0
212.9
149
64
A11CC03
ATC
alfacalcidol; systemic
27.9
208.4
148
66
Z2446
NOMESCO Finland
Social worker
12.4
197.7
232
264
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
63.2
193.3
108
20
Z49.0
ICD-10 Finland
Preparatory care for dialysis
46.8
181.1
108
27
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
48.0
180.6
107
26
Z3226
NOMESCO Finland
Physiotherapist
7.8
170.4
358
799
N18.0
ICD-10 Finland
End-stage renal disease
46.7
169.5
101
25
Z94.0
ICD-10 Finland
Kidney transplant status
41.3
157.8
97
27
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
9.8
154.7
213
294
127
Kela drug reimbursment
Transplant complication
28.7
153.4
106
43
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.7
145.1
181
219
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
12.0
139.4
156
162
B03XA02
ATC
darbepoetin alfa; parenteral
22.5
138.2
105
54
ZX120
NOMESCO Finland
Intravenous
8.4
135.0
213
342
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
10.5
130.8
162
193
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
27.6
129.2
90
37
R4110
NOMESCO Finland
Physiotherapy
6.0
128.9
425
1379
A12AA04
ATC
calcium carbonate; oral
24.4
128.4
94
44
RD210, ,
NOMESCO Finland
23.6
128.0
95
46
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
49.8
123.2
72
16
L04AA06
ATC
mycophenolic acid; systemic
18.4
121.3
101
63
V03AE01
ATC
polystyrene sulfonate; oral
32.2
118.5
78
27
L04AD02
ATC
tacrolimus; systemic
29.4
116.4
79
30
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
44.7
115.2
69
17
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
266.7
113.2
113
5
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
16.7
113.0
99
68
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
50.9
111.8
65
14
KA1AE
NOMESCO Finland
Kidney ultrasound examination
16.0
109.4
98
70
ZXD10
NOMESCO Finland
Scheduled procedure
5.4
109.3
470
1836
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
32.7
108.6
71
24
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.5
96.5
553
2622
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.1
96.5
103
98
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
9.2
92.5
123
158
Z49.2
ICD-10 Finland
Other dialysis
38.5
91.7
57
16
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.3
90.8
236
599
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
33.1
89.3
58
19
N18.8
ICD-10 Finland
Other chronic renal failure
17.4
87.5
74
47
ZXE10
NOMESCO Finland
More than one and less than three hours
4.4
87.2
423
1729
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
4.7
85.4
273
816
RS221, ,
NOMESCO Finland
17.3
84.9
72
46
ZXE00
NOMESCO Finland
One hour or less
4.3
83.9
442
1902
XF400
NOMESCO Finland
ECG with 12 standard connections
4.9
82.8
236
642
RS220, ,
NOMESCO Finland
22.9
82.2
61
29
137
Kela drug reimbursment
Uraemia requiring dialysis
26.9
79.1
55
22
WX892
NOMESCO Finland
Monitored bed care
6.4
78.1
148
279
WX202
NOMESCO Finland
Supraclavicular plexus blockade
17.2
77.8
66
42
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.6
77.8
254
765
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.5
77.1
178
403
ZXE20
NOMESCO Finland
More than three and less than five hours
4.8
76.0
217
587
3AC01, ,
NOMESCO Finland
31.5
75.9
50
17
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
75.3
71
*
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
16.5
75.1
65
43
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
14.8
75.1
69
51
ZXA05
NOMESCO Finland
Left side
4.1
72.8
299
1058
TK810
NOMESCO Finland
Hemofiltration
31.3
71.2
47
16
H05BX01
ATC
cinacalcet; oral
32.7
70.6
46
15
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.4
69.8
163
371
B05DA
ATC
Isotonic solutions
27.0
69.2
48
19
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.5
66.4
119
211
XPX08
NOMESCO Finland
Intraoperative flow measurement
22.8
66.2
49
23
Z3229
NOMESCO Finland
Other healthcare associate professional
5.5
66.0
147
320
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
6.2
64.2
122
229
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
6.3
63.5
119
220
B05DB
ATC
Hypertonic solutions
29.6
62.6
42
15
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
341.0
62.4
62
*
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
92.1
61.1
67
8
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
8.2
60.1
85
116
WX203
NOMESCO Finland
Infraclavicular plexus blockade
10.7
59.5
67
68
WW500
NOMESCO Finland
Blood transfusion
7.7
59.3
89
130
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
58.9
308
1249
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.1
58.2
94
149
C03CA01
ATC
furosemide; systemic
3.5
58.0
298
1193
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
21.2
57.8
44
22
ZXA00
NOMESCO Finland
Right side
3.5
57.6
298
1198
V03AE02
ATC
sevelamer; oral
86.1
57.0
63
8
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.6
56.2
158
415
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
6.8
56.0
94
155
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
14.7
55.8
51
37
WX002
NOMESCO Finland
Sedation and analgesia
3.7
54.8
233
822
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
4.6
54.7
154
404
TKC20
NOMESCO Finland
Catheterisation of bladder
5.8
54.1
109
215
RS222, ,
NOMESCO Finland
17.1
53.4
45
28
GD1LA
NOMESCO Finland
GD
14.5
53.2
49
36
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
5.8
52.6
106
209
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.3
52.6
160
445
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.6
49.9
208
719
JN4BD
NOMESCO Finland
Extensive body CT
4.4
49.9
147
398
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
74.1
48.8
55
8
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
6.0
48.6
93
174
TPH04
NOMESCO Finland
Cathetrisation of vein
3.3
47.6
257
1040
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
7.0
46.9
75
117
ZY010
NOMESCO Finland
Hospital outpatient
5.3
46.3
101
213
R4120
NOMESCO Finland
Occupational therapy
4.9
46.2
113
263
V03AE03
ATC
lanthanum carbonate; oral
63.3
46.0
53
9
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
7.1
45.9
73
113
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
45.8
309
1417
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
167.1
45.4
47
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
45.3
235
925
TPH07
NOMESCO Finland
Cathetrisation of artery
3.9
44.4
154
467
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
5.1
44.1
101
222
WX730
NOMESCO Finland
Conventional respirator
14.0
43.7
41
31
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.0
43.2
102
230
196
Kela drug reimbursment
Paricalcitol and cinacalcet
59.5
43.0
50
9
J01MA12
ATC
levofloxacin; systemic
3.3
42.9
213
814
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
11.4
42.1
45
42
ZXA10
NOMESCO Finland
Bilateral
3.3
41.9
196
721
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.5
41.8
112
280
XCK10
NOMESCO Finland
Photography of fundus of eye
4.1
41.1
129
363
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
10.6
41.1
46
46
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.3
40.6
88
184
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
4.9
40.5
96
217
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.4
39.9
84
171
L04AD01
ATC
ciclosporin; systemic
9.6
39.9
48
53
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
61.2
39.8
46
8
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.1
39.6
90
196
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.2
39.6
88
188
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
39.3
287
1351
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
8.8
38.1
49
59
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
8.8
38.1
49
59
ZXD05
NOMESCO Finland
Urgent procedure
2.8
37.3
293
1426
H02AB04
ATC
methylprednisolone; systemic
3.4
37.1
162
567
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.1
35.4
79
169
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
35.1
185
723
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
34.7
117
345
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
5.5
33.9
69
136
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
341.8
33.2
33
*
WX882
NOMESCO Finland
High dependency care
6.5
33.2
56
92
N19
ICD-10 Finland
Unspecified kidney failure
5.8
33.0
63
117
ZY000
NOMESCO Finland
Hospital inpatient
10.5
32.9
37
37
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
32.6
247
1166
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
32.5
31
*
TQW40
NOMESCO Finland
Remowal of suture of skin
4.1
31.8
96
261
R50.9
ICD-10 Finland
Fever, unspecified
3.0
31.6
172
681
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
73.3
31.1
35
5
B01AB04
ATC
dalteparin; parenteral
5.1
31.0
69
147
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.6
30.8
77
181
R4190
NOMESCO Finland
Nutritional therapy
5.0
30.8
69
148
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.6
30.6
40
49
L28
ICPC
Limited function/disability (L)
2.9
30.6
176
717
C02AC05
ATC
moxonidine; oral
4.8
30.6
73
165
NHQ40
NOMESCO Finland
Amputation of toe
8.7
30.2
39
47
EBA15
NOMESCO Finland
Extraction of multiple teeth
5.2
29.3
63
130
J01MA14
ATC
moxifloxacin; systemic
3.6
29.3
109
342
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
303.5
29.0
29
*
A51.0
ICD-10 Finland
Primary genital syphilis
303.5
29.0
29
*
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
50.8
28.6
34
7
A28
ICPC
Limited function/disability NOS
2.9
28.5
164
666
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.5
28.4
111
359
A41.9
ICD-10 Finland
Sepsis, unspecified
5.8
28.3
54
100
H02AB07
ATC
prednisone; oral
3.1
28.1
134
490
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
5.3
28.0
58
116
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.3
27.5
115
388
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.2
26.7
124
445
ZXD35
NOMESCO Finland
Usual procedure
5.5
26.6
53
102
UJF30
NOMESCO Finland
Ileoscopy through colon
3.3
26.4
115
397
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.8
26.2
62
139
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
25.2
25.9
36
15
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
7.8
25.7
36
48
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.9
25.7
59
129
Z71.8
ICD-10 Finland
Other specified counselling
2.3
25.2
307
1759
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
5.8
25.2
47
85
J01FF01
ATC
clindamycin; systemic
2.4
25.2
250
1313
B03XA01
ATC
erythropoietin; parenteral
22.2
25.0
36
17
J01MA02
ATC
ciprofloxacin; systemic
2.3
24.9
328
1938
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.6
24.9
62
145
321
Kela drug reimbursment
Paricalcitol and cinacalcet
23.7
24.1
34
15
U14
ICPC
Kidney symptom/complaint
8.3
24.0
32
40
205
Kela drug reimbursment
Chronic hypertension
2.4
23.9
213
1063
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.5
23.8
90
284
C08CA01
ATC
amlodipine; oral
2.2
23.7
321
1910
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.5
23.5
89
281
XF404
NOMESCO Finland
Ambulatory ECG
3.3
23.3
95
314
TK820
NOMESCO Finland
Peritoneal dialysis
25.7
23.2
32
13
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
25.7
23.2
32
13
WX110, ,
SPAT
3.7
23.2
77
223
WX872
NOMESCO Finland
Intensive care
4.0
23.1
70
190
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
+∞
23.0
22
*
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
26.9
22.8
31
12
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
237.1
22.7
23
*
ZX114
NOMESCO Finland
Intramuscular
7.5
22.6
33
46
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
9.1
22.5
28
32
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.5
22.4
81
248
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
5.3
22.4
46
91
AA1AD
NOMESCO Finland
CT of head and brain
2.3
22.1
246
1344
A53.9
ICD-10 Finland
Syphilis, unspecified
+∞
22.0
21
*
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
22.0
21
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
7.4
21.8
32
45
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
8.5
21.5
28
34
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
7.5
21.3
31
43
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
3.6
21.2
75
226
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.8
21.2
68
192
N05CD07
ATC
temazepam; oral
3.0
20.8
104
387
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.2
20.8
91
314
N05CF01
ATC
zopiclone; oral
2.2
20.7
263
1507
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.7
20.4
48
107
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.7
20.1
48
108
K02.9
ICD-10 Finland
Dental caries, unspecified
6.2
20.1
35
59
A63.0
ICD-10 Finland
Anogenital (venereal) warts
4.7
19.9
47
105
WX722
NOMESCO Finland
PEEP
3.8
19.9
64
181
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.2
19.8
54
135
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
6.1
19.8
35
60
WNF00
NOMESCO Finland
Infection source and contact determination
29.9
19.8
26
9
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.2
19.7
84
285
A46
ICD-10 Finland
Erysipelas
2.5
19.6
145
658
Z2445
NOMESCO Finland
Psychologist
3.9
19.5
60
164
WX110
NOMESCO Finland
Infiltration anesthesia
2.3
19.5
576
4491
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.9
19.4
44
95
IGY02
NOMESCO Finland
Psychiatric monitoring contact
4.1
19.4
55
142
X57
ICD-10 Finland
Unspecified privation
5.6
19.2
37
69
K65.0
ICD-10 Finland
Acute peritonitis
14.7
18.7
31
22
PBU99
NOMESCO Finland
Other repair after previous reconstruction of arteries of upper extremity
194.8
18.6
19
*
WX402
NOMESCO Finland
General anaesthesia
2.2
18.5
201
1075
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.7
18.2
43
96
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.0
18.2
85
304
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
6.9
18.0
28
42
B99
ICD-10 Finland
Other and unspecified infectious diseases
6.2
17.9
31
52
I77.0
ICD-10 Finland
Arteriovenous fistula, acquired
68.4
17.8
20
*
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
68.4
17.8
20
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.2
17.8
37
74
A51.9
ICD-10 Finland
Early syphilis, unspecified
+∞
17.8
17
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.6
17.8
62
185
ZXD20
NOMESCO Finland
Day surgery
2.6
17.6
117
503
A06AD11
ATC
lactulose; oral
2.6
17.6
117
503
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
97.5
17.6
19
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
17.6
175
901
AB14W, ,
NOMESCO Finland
184.3
17.6
18
*
WX213
NOMESCO Finland
Lower leg blockade
17.5
17.5
27
16
TQW11
NOMESCO Finland
Vacuum treatment of wound
5.6
17.3
33
61
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.0
17.2
247
1464
B01AB10
ATC
tinzaparin; parenteral
2.6
17.0
105
436
RJ129, ,
NOMESCO Finland
+∞
16.7
16
*
ZX100
NOMESCO Finland
Oral
6.9
16.7
26
39
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
16.6
108
460
A54.5
ICD-10 Finland
Gonococcal pharyngitis
173.8
16.6
17
*
RJ420, ,
NOMESCO Finland
20.6
16.5
24
12
L04AX01
ATC
azathioprine; systemic
3.9
16.4
49
131
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.7
16.2
54
156
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
17.2
16.2
25
15
N03AX16
ATC
[U] pregabalin
2.1
16.1
190
1043
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.4
15.9
121
553
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
17.7
15.7
24
14
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
12.1
15.7
28
24
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
87.0
15.6
17
*
C07AB07
ATC
bisoprolol; oral
1.9
15.6
360
2484
E87.5
ICD-10 Finland
Hyperkalaemia
6.4
15.6
26
42
B01AC04
ATC
clopidogrel; oral
2.3
15.6
140
689
A10AC01
ATC
insulin (human); parenteral
2.9
15.5
79
296
KBV00
NOMESCO Finland
Insertion of stent into ureter
15.2
15.4
25
17
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
15.2
15.4
25
17
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.8
15.4
80
303
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.1
15.3
43
110
GD1AD
NOMESCO Finland
Thorax CT examination
3.0
15.3
70
247
A10AB05
ATC
insulin aspart; parenteral
2.7
15.3
85
334
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
20.6
15.2
22
11
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
15.1
168
899
B01AA03
ATC
warfarin; systemic
2.3
15.1
133
648
B18.2
ICD-10 Finland
Chronic viral hepatitis C
5.9
15.0
27
47
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
12.8
15.0
26
21
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
15.5
15.0
24
16
XF600
NOMESCO Finland
Bloodpressure measurement
3.1
14.9
65
223
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
5.2
14.9
31
62
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.0
14.9
32
66
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
57.9
14.8
17
*
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
18.9
14.8
22
12
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
14.7
175
960
Y25
ICPC
Fear sexually transm disease male
4.4
14.7
37
87
R11
ICD-10 Finland
Nausea and vomiting
2.7
14.7
86
347
XW000
NOMESCO Finland
Bone marrow biopsy
3.8
14.6
45
123
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.1
14.5
40
101
RJ414, ,
NOMESCO Finland
36.8
14.5
18
5
ZX108
NOMESCO Finland
Inhalation
12.9
14.5
25
20
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
5.2
14.4
30
60
H3603, E103,
ICD-10 Finland
11.7
14.4
26
23
M04AA01
ATC
allopurinol; systemic
2.4
14.3
109
498
S97
ICPC
Chronic ulcer skin
2.9
14.3
69
251
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
3.3
14.1
55
176
K05.31
ICD-10 Finland
Periodontitis pronounced
2.4
14.1
106
481
C09AA02
ATC
enalapril; systemic
2.1
14.0
151
797
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.5
13.9
34
78
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.0
13.9
30
62
F43.29
ICD-10 Finland
Adaptation disorder UNS
4.6
13.9
33
74
A12AA12
ATC
[U] calcium acetate
54.4
13.9
16
*
A10AE04
ATC
insulin glargine; parenteral
2.5
13.8
98
433
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.4
13.8
99
440
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
13.7
89
377
XF402
NOMESCO Finland
ECG with work load test
2.5
13.7
92
396
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.0
13.6
63
224
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
26.3
13.4
18
7
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.7
13.3
73
284
N02AX02
ATC
tramadol; systemic, rectal
1.8
13.3
335
2338
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.3
13.2
50
157
RJ120, ,
NOMESCO Finland
40.9
13.2
16
*
EB1WA, ,
NOMESCO Finland
12.5
13.2
23
19
RJ411, ,
NOMESCO Finland
15.4
13.2
21
14
C07AG02
ATC
carvedilol; oral
3.1
13.1
57
195
XCH00
NOMESCO Finland
Eye pressure measurement
3.4
13.1
47
143
A07AA09
ATC
vancomycin; oral
9.6
13.1
26
28
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
9.6
13.1
26
28
H43.1
ICD-10 Finland
Vitreous haemorrhage
4.4
13.0
33
78
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.9
13.0
39
105
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
13.0
150
811
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.7
12.8
42
120
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
14.4
12.8
21
15
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
14.4
12.8
21
15
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
14.4
12.8
21
15
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
4.1
12.8
35
88
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
5.6
12.7
24
44
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
10.3
12.6
24
24
L04AA01
ATC
[U] ciclosporin
10.3
12.6
24
24
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
10.3
12.6
24
24
3025
Kela drug reimbursment
Calcium carbonate
13.5
12.5
21
16
J05AB11
ATC
valaciclovir; oral
2.2
12.5
125
639
WW200, ,
SPAT
0.4
12.4
71
1538
I50.9
ICD-10 Finland
Heart failure, unspecified
2.3
12.3
99
462
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
4.1
12.3
34
86
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.4
12.3
95
436
KH1EE
NOMESCO Finland
Urologic ultrasound examination
38.2
12.2
15
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
12.2
110
539
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
12.1
320
2246
5AB14, ,
NOMESCO Finland
27.2
12.1
16
6
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
21.7
12.0
17
8
K99
ICPC
Cardiovascular disease other
5.0
12.0
26
54
TGC00
NOMESCO Finland
Bronchial lavation
4.0
11.9
34
88
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
4.3
11.9
31
75
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
11.9
86
383
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
5.5
11.9
23
43
C08DB01
ATC
diltiazem; oral
3.5
11.8
41
122
A41.8
ICD-10 Finland
Other specified sepsis
5.0
11.8
25
51
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.4
11.7
83
366
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
12.8
11.7
20
16
6BA02, ,
NOMESCO Finland
30.6
11.7
15
5
HA1AA
NOMESCO Finland
X-ray mammography
2.8
11.6
62
238
A07AA02
ATC
nystatin; oral
3.1
11.6
49
165
J45.1
ICD-10 Finland
Nonallergic asthma
2.7
11.6
66
262
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
9.5
11.6
23
25
P01AB01
ATC
metronidazole; oral, rectal
1.7
11.5
284
1948
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.7
11.5
66
263
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
4.8
11.5
26
56
AB18W, ,
NOMESCO Finland
+∞
11.5
11
*
H05BX02
ATC
paricalcitol; systemic
+∞
11.5
11
*
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
3.3
11.4
43
135
A10AE05
ATC
insulin detemir; parenteral
2.8
11.4
58
217
A10AB04
ATC
insulin lispro; parenteral
3.4
11.4
41
125
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.3
11.4
29
69
RS230, ,
NOMESCO Finland
15.3
11.3
18
12
J01CF05
ATC
flucloxacillin; systemic
2.5
11.3
73
308
C02CA01
ATC
prazosin; oral
9.1
11.3
23
26
N30.0
ICD-10 Finland
Acute cystitis
2.1
11.3
111
562
TQW99
NOMESCO Finland
Other minor procedure on skin
3.0
11.3
50
173
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
35.6
11.3
14
*
WX212
NOMESCO Finland
Femoral plexus blockade
4.6
11.3
27
61
ZX112
NOMESCO Finland
Subcutaneous
4.4
11.1
28
66
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.9
11.1
175
1048
WYA30, ,
SPAT
10.3
11.1
21
21
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.7
11.0
35
98
J01DB01
ATC
cefalexin; oral
2.0
11.0
614
5278
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.9
10.9
32
85
EB1AA, ,
SPAT
2.6
10.8
63
253
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.0
10.8
49
172
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
5.0
10.8
23
47
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.8
10.8
33
90
Z94.4
ICD-10 Finland
Liver transplant status
18.1
10.8
16
9
N25.0
ICD-10 Finland
Renal osteodystrophy
28.5
10.8
14
5
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
10.7
112
580
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.6
10.7
35
100
K02.2
ICD-10 Finland
Caries of cementum
3.0
10.7
49
173
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.4
10.7
39
120
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
4.0
10.7
30
77
C08CA02
ATC
felodipine; oral
2.5
10.7
70
298
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.4
10.6
73
317
A02BC02
ATC
pantoprazole; systemic
1.7
10.6
496
4013
N05BA01
ATC
diazepam; systemic, rectal
2.1
10.6
105
533
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.5
10.6
69
293
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.8
10.5
32
87
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
111.6
10.4
11
*
N02AA05
ATC
oxycodone; systemic
2.0
10.4
136
763
1AD02, ,
NOMESCO Finland
+∞
10.4
10
*
B23
ICD-10 Finland
Human immunodeficiency virus [HIV] disease resulting in other conditions
+∞
10.4
10
*
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
10.4
10
*
C02EA02, ,
ATC
3.6
10.4
34
97
A12BA01
ATC
potassium chloride; oral
3.6
10.4
34
97
RK320, ,
NOMESCO Finland
12.3
10.4
18
15
QDA10
NOMESCO Finland
Incision of skin of lower limb
12.3
10.4
18
15
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
8.4
10.4
22
27
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
33.0
10.4
13
*
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
4.5
10.3
25
57
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
10.8
10.3
19
18
H3601, E113,
ICD-10 Finland
5.0
10.3
22
45
H02AB09
ATC
hydrocortisone; systemic
4.1
10.3
28
70
Z5132
NOMESCO Finland
Nursing associate professional
9.8
10.3
20
21
N30.9
ICD-10 Finland
Cystitis, unspecified
2.9
10.2
50
183
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.2
10.2
27
66
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.6
10.2
61
248
C08CA13
ATC
lercanidipine; oral
2.0
10.2
115
613
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
5.4
10.2
20
38
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.8
10.1
170
1036
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
11.5
10.1
18
16
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
5.1
10.1
21
42
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
5.1
10.1
21
42
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
5.1
10.1
21
42
NF1AA
NOMESCO Finland
Hip X-ray examination
2.4
10.1
72
319
R4140
NOMESCO Finland
Psychotherapy
14.8
10.0
16
11
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
3.1
10.0
41
136
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
9.9
64
270
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.3
9.8
37
116
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
26.4
9.8
13
5
R03BB04
ATC
tiotropium bromide; inhalant
2.3
9.8
78
362
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.4
9.7
68
298
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
13.6
9.7
16
12
A56.4
ICD-10 Finland
Chlamydial infection of pharynx
55.7
9.7
11
*
T89
ICPC
Diabetes insulin dependent
2.8
9.6
50
189
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
11.6
9.6
17
15
NGQ20
NOMESCO Finland
Amputation of lower leg
10.2
9.6
18
18
J01DA01
ATC
[U] cefalexin
1.6
9.5
435
3451
I50.0
ICD-10 Finland
Congestive heart failure
2.6
9.5
54
214
M10.9
ICD-10 Finland
Gout, unspecified
2.5
9.5
62
263
Z99.2
ICD-10 Finland
Dependence on renal dialysis
30.5
9.4
12
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
30.5
9.4
12
*
Z20.6
ICD-10 Finland
Contact with and exposure to human immunodeficiency virus [HIV]
+∞
9.4
9
*
R2110
NOMESCO Finland
Giving the first information
2.8
9.4
49
186
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.8
9.4
46
169
I95.9
ICD-10 Finland
Hypotension, unspecified
5.0
9.4
20
41
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
4.8
9.3
21
45
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.5
9.3
59
247
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
3.6
9.3
31
90
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
7.4
9.3
21
29
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.8
9.3
46
170
D64.8
ICD-10 Finland
Other specified anaemias
4.7
9.1
21
46
R5110, ,
SPAT
2.3
9.1
68
307
H3603, E107,
ICD-10 Finland
37.2
9.0
11
*
TK830
NOMESCO Finland
Ultrafiltration
37.2
9.0
11
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
9.0
53
214
SPAT1153
SPAT
Removal of sutures
0.5
9.0
81
1504
C01DA14
ATC
isosorbide mononitrate; oral
2.1
9.0
96
501
A10AA02, ,
ATC
3.2
8.9
36
118
KAC00
NOMESCO Finland
Nephrectomy
24.3
8.9
12
5
WX214
NOMESCO Finland
Plexus blockade at the ankle
12.7
8.9
15
12
TNG34
NOMESCO Finland
Major custom moulded orthopaedic cast, knee or lower leg
5.0
8.9
19
39
A02BC01
ATC
omeprazole; systemic
1.7
8.8
186
1206
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
10.9
8.8
16
15
J01MA06
ATC
norfloxacin; oral
2.1
8.8
89
455
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.0
8.8
38
130
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.6
8.7
51
205
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.1
8.7
37
125
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.6
8.7
29
84
A97
ICPC
No disease
1.8
8.7
154
949
WW400
NOMESCO Finland
Plasmaferesis
50.6
8.7
10
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
8.7
109
602
D07AB08
ATC
desonide; topical
2.1
8.7
88
450
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.8
8.7
26
70
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.5
8.6
56
237
A04
ICPC
Weakness/tiredness general
1.9
8.6
114
641
S91.3
ICD-10 Finland
Open wound of other parts of foot
3.3
8.6
32
100
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
16.5
8.6
13
8
OAB43, ,
SPAT
0.5
8.6
108
1803
5AH02, ,
NOMESCO Finland
27.9
8.5
11
*
U13
ICPC
Bladder symptom/complaint other
3.7
8.5
27
76
A10AB01
ATC
insulin (human); parenteral
3.0
8.4
38
133
NK3AT
NOMESCO Finland
Muscle puncture with ultrasound guidance
91.1
8.4
9
*
KAS40
NOMESCO Finland
Excision of transplanted kidney
91.1
8.4
9
*
Z3232
NOMESCO Finland
Midwife
2.7
8.4
46
179
PD5BD
NOMESCO Finland
Extensive CT of aorta
5.0
8.4
18
37
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.5
8.4
54
228
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
8.3
103
566
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
10.9
8.3
15
14
K08.3
ICD-10 Finland
Retained dental root
2.2
8.3
69
326
TAB00
NOMESCO Finland
Lumbar puncture
2.7
8.3
44
169
JN4AD
NOMESCO Finland
Body CT examination
2.0
8.2
89
466
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
3.8
8.2
25
68
I15.0
ICD-10 Finland
Renovascular hypertension
14.7
8.2
13
9
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.2
8.2
72
348
N05BA06
ATC
lorazepam; systemic, sublingual
2.6
8.1
47
188
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
33.7
8.1
10
*
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
33.7
8.1
10
*
WX610
NOMESCO Finland
Patient controlled analgesia
9.1
8.1
16
18
RK110, ,
NOMESCO Finland
10.2
8.1
15
15
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
6.4
8.1
20
32
RD112, ,
NOMESCO Finland
22.3
8.0
11
5
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
22.3
8.0
11
5
RK290, ,
NOMESCO Finland
22.3
8.0
11
5
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
3.4
8.0
28
84
J04AB02
ATC
rifampicin; systemic
7.4
8.0
18
25
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.8
8.0
24
65
J05AB01
ATC
aciclovir; systemic
1.7
8.0
151
948
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
4.0
7.9
22
56
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
7.9
7.9
17
22
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
6.2
7.9
20
33
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.3
7.9
29
90
L84
ICD-10 Finland
Corns and callosities
3.1
7.9
33
111
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
8.6
7.8
16
19
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
3.9
7.7
22
57
4AA12, ,
NOMESCO Finland
15.2
7.7
12
8
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
15.2
7.7
12
8
ZX197, ,
NOMESCO Finland
45.5
7.7
9
*
J01FA06
ATC
roxithromycin; oral
1.6
7.7
269
1970
H3603, E113,
ICD-10 Finland
7.5
7.7
17
23
N06AB04
ATC
citalopram; systemic
1.8
7.7
142
884
N05BA04
ATC
oxazepam; oral
1.7
7.6
184
1231
ZX199
NOMESCO Finland
Other rote
18.6
7.6
11
6
PD4CM
NOMESCO Finland
Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet
25.3
7.6
10
*
WX290, ,
SPAT
2.9
7.6
34
119
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
7.6
186
1251
J12.8
ICD-10 Finland
Other viral pneumonia
10.2
7.6
14
14
UJH02
NOMESCO Finland
Anoscopy
2.8
7.6
37
136
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
7.6
253
1834
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.9
7.5
35
125
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
7.2
7.5
17
24
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.2
7.5
17
24
B07.9
ICD-10 Finland
Verruca simplex
2.8
7.5
36
131
H04AA01
ATC
glucagon; nasal, parenteral
3.6
7.5
24
68
M79.6
ICD-10 Finland
Pain in limb
1.5
7.4
305
2312
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
7.4
60
280
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.1
7.4
31
104
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
80.9
7.4
8
*
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
80.9
7.4
8
*
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
80.9
7.4
8
*
PG5ST
NOMESCO Finland
Endovascular thrombolysis of arterio-venous shunt for dialysis with radiological guidance
80.9
7.4
8
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
7.4
420
3415
XQ800
NOMESCO Finland
Prick test
2.3
7.4
57
261
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.3
7.4
56
255
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
3.0
7.3
31
105
RS224, ,
NOMESCO Finland
9.5
7.3
14
15
R80
ICD-10 Finland
Isolated proteinuria
9.5
7.3
14
15
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.7
7.3
141
888
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
3.4
7.3
26
79
PBU81
NOMESCO Finland
Thrombectomy in arteriovenous fistula from artery of upper extremity
+∞
7.3
7
*
N0832, E102,
ICD-10 Finland
+∞
7.3
7
*
A55
ICD-10 Finland
Chlamydial lymphogranuloma (venereum)
+∞
7.3
7
*
N0832, E112,
ICD-10 Finland
+∞
7.3
7
*
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.9
7.3
21
55
WX320
NOMESCO Finland
Spinalanesthesy
1.7
7.3
166
1093
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
5.9
7.3
19
33
RJ410, ,
NOMESCO Finland
15.9
7.2
11
7
N05AA02
ATC
levomepromazine; systemic
2.7
7.2
38
145
XQ848
NOMESCO Finland
Dermatological photography
3.1
7.2
29
95
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.7
7.2
22
60
H25.1
ICD-10 Finland
Senile nuclear cataract
1.7
7.2
153
988
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.8
7.2
35
128
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
7.4
7.2
16
22
M01AE01
ATC
ibuprofen; systemic, rectal
0.6
7.2
542
6022
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
3.2
7.2
28
90
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.0
7.2
80
423
M01AH05
ATC
etoricoxib; oral
0.7
7.2
299
3762
M05BA04
ATC
alendronic acid; oral
2.3
7.2
52
232
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.3
7.2
26
80
N05AH02
ATC
clozapine; systemic
3.4
7.2
25
75
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
30.3
7.2
9
*
XX9XW, ,
NOMESCO Finland
8.0
7.1
15
19
OAB42, ,
SPAT
0.3
7.1
22
646
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
6.1
7.1
18
30
TDA90
NOMESCO Finland
Removal wax from ear
6.1
7.1
18
30
Z94.1
ICD-10 Finland
Heart transplant status
12.2
7.1
12
10
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.9
7.1
33
118
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
8.9
7.1
14
16
K92.1
ICD-10 Finland
Melaena
2.5
7.1
43
177
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
10.2
7.1
13
13
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.3
7.0
26
81
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
7.1
7.0
16
23
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.4
7.0
17
39
H3601, E103,
ICD-10 Finland
6.4
7.0
17
27
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
7.0
73
378
D50.8
ICD-10 Finland
Other iron deficiency anaemias
5.5
7.0
19
35
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
6.9
191
1318
RS121, ,
NOMESCO Finland
7.6
6.9
15
20
Z29.9
ICD-10 Finland
Prophylactic measure, unspecified
13.9
6.9
11
8
RT250, ,
NOMESCO Finland
13.9
6.9
11
8
M01AC06
ATC
meloxicam; systemic, rectal
0.6
6.9
119
1839
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.5
6.9
42
173
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
6.9
129
805
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.8
6.9
34
126
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.9
6.8
20
53
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.1
6.8
28
93
WX720
NOMESCO Finland
Own respiration
0.0
6.8
*
200
5BA08, ,
NOMESCO Finland
11.1
6.8
12
11
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
11.1
6.8
12
11
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.2
6.8
26
83
RJ425, ,
NOMESCO Finland
40.4
6.8
8
*
RJ521, ,
NOMESCO Finland
40.4
6.8
8
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
40.4
6.8
8
*
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.7
6.8
123
761
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
3.6
6.8
22
63
RS120, ,
NOMESCO Finland
16.9
6.8
10
6
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
16.9
6.8
10
6
R31
ICD-10 Finland
Unspecified haematuria
2.0
6.7
78
419
JLE03
NOMESCO Finland
Allogenic total transplantation of pancreas with pancreaticoenterostomy
22.7
6.7
9
*
K65.9
ICD-10 Finland
Peritonitis, unspecified
22.7
6.7
9
*
3A064, ,
NOMESCO Finland
22.7
6.7
9
*
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
22.7
6.7
9
*
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.6
6.7
199
1398
WX204
NOMESCO Finland
Axillary plexus blockaced
2.7
6.7
34
128
Z50.1
ICD-10 Finland
Other physical therapy
2.5
6.7
42
176
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.1
6.6
66
335
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
5.6
6.6
18
33
N20.9
ICD-10 Finland
Urinary calculus, unspecified
3.2
6.6
25
79
F99
ICD-10 Finland
Mental disorder, not otherwise specified
3.5
6.6
22
64
M10.3
ICD-10 Finland
Gout due to impairment of renal function
10.1
6.5
12
12
CD2S4
NOMESCO Finland
Photography of eye
10.1
6.5
12
12
N05AH03
ATC
olanzapine; systemic
2.2
6.5
57
275
J20
ICD-10 Finland
Acute bronchitis
1.9
6.5
80
438
ULA02
NOMESCO Finland
Kolposcopy
2.2
6.5
52
242
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.7
6.5
20
55
OAA67, ,
SPAT
0.4
6.5
43
903
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.7
6.5
33
124
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.9
6.5
30
107
N06AX11
ATC
mirtazapine; oral
1.5
6.5
237
1741
E10
ICD-10 Finland
Type 1 diabetes mellitus
3.5
6.5
22
65
RJ122, ,
NOMESCO Finland
70.4
6.4
7
*
B90
ICPC
HIV-infection/AIDS
70.4
6.4
7
*
I12.9
ICD-10 Finland
Hypertensive renal disease without renal failure
70.4
6.4
7
*
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
70.4
6.4
7
*
A10AA01, ,
ATC
2.9
6.4
29
102
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
14.5
6.4
10
7
1CX08, ,
NOMESCO Finland
14.5
6.4
10
7
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
14.5
6.4
10
7
M10.0
ICD-10 Finland
Idiopathic gout
2.7
6.4
33
125
CKC12
NOMESCO Finland
Photocoagulation of retina
2.5
6.4
39
161
R1250
NOMESCO Finland
Evaluation of functional capability
3.2
6.4
25
81
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
6.4
51
238
PE1AT
NOMESCO Finland
Femoral artery PTA
6.0
6.3
16
27
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
11.1
6.3
11
10
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
11.1
6.3
11
10
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.1
6.3
59
293
RJ126, ,
NOMESCO Finland
18.2
6.3
9
5
K65.8
ICD-10 Finland
Other peritonitis
18.2
6.3
9
5
RJ210, ,
NOMESCO Finland
18.2
6.3
9
5
306
Kela drug reimbursment
Erythropoietin and darbepoetin
18.2
6.3
9
5
B01AB05
ATC
enoxaparin; parenteral
1.6
6.3
203
1450
RD240, ,
NOMESCO Finland
+∞
6.3
6
*
A51.5
ICD-10 Finland
Early syphilis, latent
+∞
6.3
6
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.1
6.2
25
82
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
26.9
6.2
8
*
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
26.9
6.2
8
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.7
6.2
32
121
K63.5
ICD-10 Finland
Polyp of colon
3.2
6.2
24
77
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.7
6.2
140
917
R18
ICD-10 Finland
Ascites
3.6
6.2
20
57
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
4.0
6.2
17
43
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.3
6.2
23
72
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
7.8
6.1
13
17
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
2.5
6.1
36
146
XA800
NOMESCO Finland
Neuropsychological investigation
2.3
6.1
44
196
A10BH05
ATC
linagliptin; oral
2.4
6.1
40
171
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.3
6.1
43
190
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
8.7
6.1
12
14
ZXE90
NOMESCO Finland
More than 22 hours
10.1
6.0
11
11
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
10.1
6.0
11
11
J46
ICD-10 Finland
Status asthmaticus
3.4
6.0
21
63
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.4
6.0
21
63
NH1AD
NOMESCO Finland
Ankle and foot CT
3.4
6.0
21
63
N05CF02
ATC
zolpidem; oral
1.7
6.0
120
760
SPAT1312
SPAT
General health counselling
0.6
6.0
91
1464
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 500 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Proper column names.
- Show details (e.g. Fisher or Chi-square test, N cases and N controls) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV not working.
- No filters and sorters.
- Limited amount of endpoints with TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP Concept
ln(OR) -5y
ln(OR) -1y
ln(OR) -1m
ln(OR) d0
ln(OR) +1m
ln(OR) +1y
ln(OR) +5y
MCC -5y
MCC -1y
MCC -1m
MCC d0
MCC +1m
MCC +1y
MCC +5y
HIV disease resulting in other specified conditions
B23.8 (45561749)
B23.8 (45561749)
Planned therapy visit for psychiatric disease
W0A12 (2001310894)
W0A12 (2001310894)
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: Unspecified
SMOKING-2-2-0 (2002330110)
SMOKING-2-2-0 (2002330110)
Plastic repair of arteriovenous fistula from artery of upper extremity
PBU84 (2001308928)
PBU84 (2001308928)
Contrast examination of injection gate to artery or vein
PG5AC (2001309722)
PG5AC (2001309722)
Immunization
WW200 (2001310599)
WW200 (2001310599)
Procedure related to previous procedure classified in chapter T
ZST00 (2001311337)
ZST00 (2001311337)
Social worker
Z2446 (2001311559)
Z2446 (2001311559)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 (2002330113)
SMOKING-2-3-0 (2002330113)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: never
SMOKING-2-3-5 (2002330114)
SMOKING-2-3-5 (2002330114)
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: Unspecified
SMOKING-1-1-0 (2002330116)
SMOKING-1-1-0 (2002330116)
Body height measure
50373000 (4177340)
50373000 (4177340)
Body mass index
60621009 (4245997)
60621009 (4245997)
HIV disease resulting in (persistent) generalized lymphadenopathy
B23.1 (45532868)
B23.1 (45532868)
Construction of arteriovenous fistula from brachial artery
PBL09 (2001308891)
PBL09 (2001308891)
Other extensive ultrasound examination of artery
PG1DE (2001309713)
PG1DE (2001309713)
Other therapy enhancing rehabilitation
R4160 (2001310240)
R4160 (2001310240)
Blood transfusion
WW500 (2001310603)
WW500 (2001310603)
Infection source and contact determination
WNF00 (2001310718)
WNF00 (2001310718)
Diarrhoea
D11 (2002000310)
D11 (2002000310)
IV_IRON - yes
IV_IRON-1 (2002330217)
IV_IRON-1 (2002330217)
lanthanum carbonate; oral
V03AE03 (21605266)
V03AE03 (21605266)
Spirometry study
18759-1 (3000492)
18759-1 (3000492)
Body weight Measured
3141-9 (3013762)
3141-9 (3013762)
Treponema pallidum Ab [Titer] in Serum by Hemagglutination
26009-1 (3019539)
26009-1 (3019539)
Reagin Ab [Titer] in Serum by VDRL
50690-7 (3029634)
50690-7 (3029634)
Unspecified human immunodeficiency virus [HIV] disease
B24 (45547443)
B24 (45547443)
Asymptomatic human immunodeficiency virus [HIV] infection status
Z21 (45566407)
Z21 (45566407)
Preparatory care for dialysis
Z49.0 (45571361)
Z49.0 (45571361)
Need for immunization against influenza
Z25.1 (45581017)
Z25.1 (45581017)
Chronic viral hepatitis C
B18.2 (45590846)
B18.2 (45590846)
Paranoid schizophrenia continuous
F20.00 (2000501920)
F20.00 (2000501920)
Immunoglobulin A (IgA) nephropathy
N08.2*D89.80 (2000503126)
N08.2*D89.80 (2000503126)
Glomerular disorders in diabetes mellitus and Type 2 diabetes mellitus, with renal complications
N08.3*E11.2 (2000504105)
N08.3*E11.2 (2000504105)
Lumbar puncture
TAB00 (2001300538)
TAB00 (2001300538)
Photography of fundus of eye
XCK10 (2001301381)
XCK10 (2001301381)
Standard cardiac ultrasound examination
FM1AE (2001303278)
FM1AE (2001303278)
Thorax extensive CT-examination
GD1BD (2001303621)
GD1BD (2001303621)
X-ray examination of the lungs in one projection
GD1PA (2001303645)
GD1PA (2001303645)
Psychiatric treatment plan, monitoring
ICB03 (2001304100)
ICB03 (2001304100)
Participation in compiling a psychiatric treatment plan
ICZ03 (2001304119)
ICZ03 (2001304119)
Dedicated profession-specific psychiatric intervention, individual
IEY05 (2001304224)
IEY05 (2001304224)
Abdominal ultrasound examination
JN3AE (2001305555)
JN3AE (2001305555)
Lumbar spine X-ray examination without contrast
NA3AA (2001307026)
NA3AA (2001307026)
Joint ultrasound examination not elsewhere classified
NK4XE (2001308469)
NK4XE (2001308469)
Construction of arteriovenous fistula from radial artery
PBL10 (2001308892)
PBL10 (2001308892)
Ultrasound examination of upper extremity veins
PH1AE (2001309445)
PH1AE (2001309445)
Removal of fixed intravenous catheter
TPH90 (2001309607)
TPH90 (2001309607)
Intraoperative flow measurement
XPX08 (2001309753)
XPX08 (2001309753)
Major dressing of wound of skin of lower limb
QDB10 (2001309970)
QDB10 (2001309970)
Infiltration anesthesia
WX110 (2001310767)
WX110 (2001310767)
Intravenous general anesthesia
WX404 (2001310807)
WX404 (2001310807)
Extensive body CT
JN4BD (2001310899)
JN4BD (2001310899)
Right side
ZXA00 (2001311346)
ZXA00 (2001311346)
Left side
ZXA05 (2001311347)
ZXA05 (2001311347)
Urgent procedure
ZXD05 (2001311386)
ZXD05 (2001311386)
Scheduled procedure
ZXD10 (2001311387)
ZXD10 (2001311387)
More than one and less than three hours
ZXE10 (2001311401)
ZXE10 (2001311401)
Procedure duration 60 to 89 minutes
ZXE11 (2001311402)
ZXE11 (2001311402)
More than three and less than five hours
ZXE20 (2001311408)
ZXE20 (2001311408)
Intraoperative use of ultrasonographic imaging
ZXM00 (2001311445)
ZXM00 (2001311445)
Intravenous
ZX120 (2001311495)
ZX120 (2001311495)
Physiotherapist
Z3226 (2001311560)
Z3226 (2001311560)
Other healthcare associate professional
Z3229 (2001311561)
Z3229 (2001311561)
Hospital inpatient
ZY000 (2001311598)
ZY000 (2001311598)
Hospital outpatient
ZY010 (2001311599)
ZY010 (2001311599)
Severe anaemia associated with chronic renal failure
138 (2001600134)
138 (2001600134)
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
320 (2001600281)
320 (2001600281)
TREATMENT - Hemodialysis, center
TREATMENT-21 (2002330236)
TREATMENT-21 (2002330236)
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
78445-4 (21492711)
78445-4 (21492711)
macrogol; oral
A06AD15 (21600575)
A06AD15 (21600575)
erythropoietin; parenteral
B03XA01 (21601133)
B03XA01 (21601133)
paracetamol; oral, parenteral, rectal
N02BE01 (21604344)
N02BE01 (21604344)
Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
1777-2 (3001467)
1777-2 (3001467)
Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21416-3 (3003510)
21416-3 (3003510)
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 (3005702)
543-9 (3005702)
Vancomycin [Mass/volume] in Serum or Plasma
20578-1 (3005715)
20578-1 (3005715)
HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
10351-5 (3013180)
10351-5 (3013180)
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 (3014162)
13956-8 (3014162)
pH of Serum or Plasma
2753-2 (3018418)
2753-2 (3018418)
Toxoplasma gondii IgA Ab [Units/volume] in Serum
22578-9 (3018921)
22578-9 (3018921)
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 (3019800)
6598-7 (3019800)
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 (3021347)
1995-0 (3021347)
Folate [Moles/volume] in Serum or Plasma
14732-2 (3021960)
14732-2 (3021960)
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 (3024950)
6357-8 (3024950)
Triglyceride [Moles/volume] in Serum or Plasma
14927-8 (3025839)
14927-8 (3025839)
Mycobacterium sp identified in Sputum by Organism specific culture
539-7 (3027544)
539-7 (3027544)
Protein [Mass/volume] in Urine
2888-6 (3037121)
2888-6 (3037121)
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 (3051552)
54067-4 (3051552)
General Practice Dentistry
1223G0001X (38003675)
1223G0001X (38003675)
Cardiology
6 (38004451)
6 (38004451)
Gastroenterology
10 (38004455)
10 (38004455)
Psychiatry
26 (38004469)
26 (38004469)
Infectious Disease
44 (38004484)
44 (38004484)
Endocrinology
46 (38004485)
46 (38004485)
Vascular Surgery
77 (38004496)
77 (38004496)
Hematology
82 (38004501)
82 (38004501)
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 (4010399)
113016006 (4010399)
Urine microscopy for crystals
167340007 (4042251)
167340007 (4042251)
Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
56990-5 (40760109)
56990-5 (40760109)
Other chronic renal failure
N18.8 (45534123)
N18.8 (45534123)
Hyperlipidaemia, unspecified
E78.5 (45537986)
E78.5 (45537986)
Atherosclerosis of arteries of extremities
I70.2 (45538421)
I70.2 (45538421)
Acute tubulo-interstitial nephritis
N10 (45543856)
N10 (45543856)
Need for immunization against other specified single viral diseases
Z25.8 (45547296)
Z25.8 (45547296)
Examination and observation for other specified reasons
Z04.8 (45552063)
Z04.8 (45552063)
Chronic kidney disease, unspecified
N18.9 (45553438)
N18.9 (45553438)
Hypertension secondary to other renal disorders
I15.1 (45557535)
I15.1 (45557535)
Predominantly allergic asthma
J45.0 (45557624)
J45.0 (45557624)
Nonallergic asthma
J45.1 (45557625)
J45.1 (45557625)
Polycystic kidney, autosomal dominant
Q61.2 (45558415)
Q61.2 (45558415)
Sleep apnoea
G47.3 (45562094)
G47.3 (45562094)
Kidney transplant status
Z94.0 (45566477)
Z94.0 (45566477)
Acute renal failure, unspecified
N17.9 (45567829)
N17.9 (45567829)
Renal osteodystrophy
N25.0 (45567833)
N25.0 (45567833)
Presence of electronic cardiac devices
Z95.0 (45571406)
Z95.0 (45571406)
Atherosclerotic heart disease
I25.1 (45596196)
I25.1 (45596196)
End-stage renal disease
N18.0 (45601717)
N18.0 (45601717)
Unspecified kidney failure
N19 (45601718)
N19 (45601718)
Fracture of tooth, open
S02.51 (45755762)
S02.51 (45755762)
Transplanted organ and tissue status
Z94 (45756534)
Z94 (45756534)
Extracorporeal dialysis
Z49.1 (45537649)
Z49.1 (45537649)
Nephrology
39 (38004479)
39 (38004479)
Phosphate [Moles/volume] in Serum or Plasma
14879-1 (3003458)
14879-1 (3003458)
pH of Venous blood
2746-6 (3012544)
2746-6 (3012544)
Outpatient Visit
OP (9202)
OP (9202)
Urea [Moles/volume] in Serum or Plasma
22664-7 (3020779)
22664-7 (3020779)
Insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E10.2 (2000503132)
N08.39*E10.2 (2000503132)
FISTULA - Fistula
FISTULA-1 (2002330212)
FISTULA-1 (2002330212)
Medical doctor
Z2221 (2001311556)
Z2221 (2001311556)
Hemodialysis
TK800 (2001305768)
TK800 (2001305768)
alfacalcidol; oral, parenteral
A11CC03 (21600818)
A11CC03 (21600818)
Iron [Moles/volume] in Serum or Plasma
14798-3 (3022948)
14798-3 (3022948)
clozapine; oral, parenteral
N05AH02 (21604542)
N05AH02 (21604542)
darbepoetin alfa; parenteral
B03XA02 (21601134)
B03XA02 (21601134)
Gas panel - Venous blood
24339-4 (3000991)
24339-4 (3000991)
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 (3000067)
2731-8 (3000067)
Physiotherapy
R4110 (2001310233)
R4110 (2001310233)
Base excess in Venous blood by calculation
1927-3 (3002032)
1927-3 (3002032)
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 (2002330215)
ANTIHYPERTENSIVE_DRUG-1 (2002330215)
Carbon dioxide [Partial pressure] in Venous blood
2021-4 (3021447)
2021-4 (3021447)
Chronic kidney disease
N18 (45582391)
N18 (45582391)
Reticulocytes/Erythrocytes in Blood
4679-7 (3027945)
4679-7 (3027945)
Magnesium [Moles/volume] in Serum or Plasma
2601-3 (3012095)
2601-3 (3012095)
calcium carbonate
A02AC01 (21600065)
A02AC01 (21600065)
calcium carbonate; oral
A12AA04 (21600863)
A12AA04 (21600863)
pH of Specimen
17433-4 (3019225)
17433-4 (3019225)
Thorax X-ray examination
GD1AA (2001303617)
GD1AA (2001303617)
prazosin; oral
C02CA01 (21600411)
C02CA01 (21600411)
Transferrin [Mass/volume] in Serum or Plasma
3034-6 (3004789)
3034-6 (3004789)
tacrolimus; oral, parenteral
L04AD02 (21603925)
L04AD02 (21603925)
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 (3007628)
19232-8 (3007628)
Short blood count panel - Blood
55429-5 (40758558)
55429-5 (40758558)
One hour or less
ZXE00 (2001311394)
ZXE00 (2001311394)
Treatment of a patient needing special arrangements
WYA30 (2001310874)
WYA30 (2001310874)
Insertion of central venous catheter through external or internal jugular vein
TPH15 (2001309600)
TPH15 (2001309600)
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 (46236098)
77397-8 (46236098)
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 (3015399)
30248-9 (3015399)
Difficulties in perfomrming procedure
ZXD30 (2001311389)
ZXD30 (2001311389)
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 (3001668)
19875-4 (3001668)
FEV1 --post bronchodilation
20155-8 (3023550)
20155-8 (3023550)
FEV1/FVC --post bronchodilation
69970-2 (42868459)
69970-2 (42868459)
FVC percent change Respiratory system
69982-7 (42868471)
69982-7 (42868471)
FEV1 percent change
69983-5 (42868472)
69983-5 (42868472)
Bacteria identified in Isolate by Culture
43409-2 (3042936)
43409-2 (3042936)
Measurement of heart muscle perfusion with exercise
XF655 (2001303392)
XF655 (2001303392)
Kidney ultrasound examination
KA1AE (2001305627)
KA1AE (2001305627)
Albumin [Mass/volume] in Serum or Plasma
1751-7 (3024561)
1751-7 (3024561)
Reticulocytes [#/volume] in Blood
14196-0 (3023520)
14196-0 (3023520)
ciclosporin; oral, parenteral
L04AD01 (21603924)
L04AD01 (21603924)
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 (3022250)
14804-9 (3022250)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 (3016431)
19072-8 (3016431)
methylprednisolone; oral, parenteral
H02AB04 (21602732)
H02AB04 (21602732)
Bacterial infection, unspecified
A49.9 (45590816)
A49.9 (45590816)
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 (3021337)
10839-9 (3021337)
mycophenolic acid; oral, parenteral
L04AA06 (21603896)
L04AA06 (21603896)
Ferritin [Mass/volume] in Serum or Plasma
2276-4 (3001122)
2276-4 (3001122)
HIV 1 and 2 tests - Meaningful Use set
75622-1 (46235355)
75622-1 (46235355)
Thorax X-ray examination outside radiological department
GD1UA (2001303652)
GD1UA (2001303652)
Venereal disease screening
171128005 (4064905)
171128005 (4064905)
FEV1/FVC
19926-5 (3011505)
19926-5 (3011505)
Forced vital capacity [Volume] Respiratory system
19870-5 (3020158)
19870-5 (3020158)
FEV1
20150-9 (3024653)
20150-9 (3024653)
Plastic And Reconstructive Surgery
24 (38004467)
24 (38004467)
dalteparin; parenteral
B01AB04 (21600975)
B01AB04 (21600975)
Monocytes/Leukocytes in Blood
26485-3 (3019069)
26485-3 (3019069)
Eosinophils/Leukocytes in Blood
26450-7 (3006504)
26450-7 (3006504)
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 (3015322)
2865-4 (3015322)
Basophils/Leukocytes in Blood
30180-4 (3022096)
30180-4 (3022096)
Normoblasts [#/volume] in Blood
715-3 (3021589)
715-3 (3021589)
Neutrophils/Leukocytes in Blood
26511-6 (3018010)
26511-6 (3018010)
Monocytes [#/volume] in Blood
26484-6 (3001604)
26484-6 (3001604)
Supplier / Service Provider
OMOP5117446 (33004)
OMOP5117446 (33004)
Basophils [#/volume] in Blood
26444-0 (3006315)
26444-0 (3006315)
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 (3043747)
32731-2 (3043747)
prednisone
A07EA03 (21600655)
A07EA03 (21600655)
prednisone; oral
H02AB07 (21602735)
H02AB07 (21602735)
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 (3043723)
32730-4 (3043723)
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 (3005229)
2868-8 (3005229)
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 (40764999)
62238-1 (40764999)
Lymphocytes/Leukocytes in Blood
26478-8 (3002030)
26478-8 (3002030)
Epithelial cells [#/volume] in Urine
30383-4 (3000850)
30383-4 (3000850)
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 (3044254)
40988-8 (3044254)
Oral Surgery
19 (38004464)
19 (38004464)
Hepatitis B virus core Ab [Presence] in Serum
16933-4 (3021879)
16933-4 (3021879)
Eosinophils [#/volume] in Blood
26449-9 (3013115)
26449-9 (3013115)
Monitored bed care
WX892 (2001310850)
WX892 (2001310850)
Oxygen [Partial pressure] in Capillary blood
2704-5 (3028626)
2704-5 (3028626)
Sytologyspecimen from mouth of uterus
XLD00 (2001306651)
XLD00 (2001306651)
Thorax CT examination
GD1AD (2001303618)
GD1AD (2001303618)
Lymphocytes [#/volume] in Blood
26474-7 (3019198)
26474-7 (3019198)
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 (46235759)
76080-1 (46235759)
Hemolysis interference index of Serum or Plasma
46424-8 (3052851)
46424-8 (3052851)
Neutrophils [#/volume] in Blood by Automated count
751-8 (3013650)
751-8 (3013650)
Systemic arterial pressure
364090009 (4238447)
364090009 (4238447)
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 (3002385)
30385-9 (3002385)
tinzaparin; parenteral
B01AB10 (21600981)
B01AB10 (21600981)
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 (3020427)
3216-9 (3020427)
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 (43055120)
72493-0 (43055120)
Ulcer of lower limb, not elsewhere classified
L97 (45591659)
L97 (45591659)
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 (3020460)
1988-5 (3020460)
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X (38003841)
207NI0002X (38003841)
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 (46237023)
77190-7 (46237023)
furosemide; oral, parenteral
C03CA01 (21601518)
C03CA01 (21601518)
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 (3005785)
13969-1 (3005785)
Measurement of bone density from two or more locations with X-ray
NK6QA (2001308500)
NK6QA (2001308500)
aPTT in Platelet poor plasma by Coagulation assay
14979-9 (3018677)
14979-9 (3018677)
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 (40763571)
60517-0 (40763571)
Limited function/disability (L)
L28 (2002000647)
L28 (2002000647)
Hepatitis C virus Ab [Presence] in Serum
16128-1 (3017143)
16128-1 (3017143)
Bicarbonate [Moles/volume] in Capillary blood
1961-2 (3015235)
1961-2 (3015235)
Type 2 diabetes mellitus, with multiple complications
E11.7 (45561950)
E11.7 (45561950)
moxonidine; oral
C02AC05 (21600401)
C02AC05 (21600401)
Internal Medicine
11 (38004456)
11 (38004456)
Outpatient Hospital
22 (8756)
22 (8756)
Paranasal sinuses X-ray examination in one projection
DM1QA (2001301761)
DM1QA (2001301761)
Abdominal X-ray examination without contrast
JN3AA (2001305553)
JN3AA (2001305553)
Bicarbonate [Moles/volume] in Venous blood
14627-4 (3027273)
14627-4 (3027273)
High dependency care
WX882 (2001310847)
WX882 (2001310847)
Erythrocytes [#/volume] in Urine
30391-7 (3002582)
30391-7 (3002582)
Bacteria identified in Blood by Culture
600-7 (3023368)
600-7 (3023368)
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 (3035995)
6768-6 (3035995)
Oxygen saturation in Capillary blood
2709-4 (3021901)
2709-4 (3021901)
High resolution CT examination of lungs
GD1DD (2001303632)
GD1DD (2001303632)
Heart failure, unspecified
I50.9 (45576879)
I50.9 (45576879)
Other diagnostic examination of periferal vessel
XPX99 (2001309755)
XPX99 (2001309755)
Emergency Room and Inpatient Visit
ERIP (262)
ERIP (262)
Type 2 diabetes mellitus, with renal complications
E11.2 (45605400)
E11.2 (45605400)
Glucose [Moles/volume] in Serum or Plasma
14749-6 (3013826)
14749-6 (3013826)
General anesthesia, balanced
WX408 (2001310808)
WX408 (2001310808)
Cardiac ultrasound examination through oesophagus
FM1BE (2001303285)
FM1BE (2001303285)
carvedilol; oral
C07AG02 (21601700)
C07AG02 (21601700)
Remowal of suture of skin
TQW40 (2001310146)
TQW40 (2001310146)
Other investigative procedure of eye
XCW99 (2001301491)
XCW99 (2001301491)
Ultrasound examination of upper part of abdomen
JN1AE (2001305517)
JN1AE (2001305517)
Occupational therapy
R4120 (2001310234)
R4120 (2001310234)
Sedation and analgesia
WX002 (2001310758)
WX002 (2001310758)
T1D - yes
T1D-1 (2002330228)
T1D-1 (2002330228)
calcium (different salts in combination); oral
A12AA20 (21600872)
A12AA20 (21600872)
Inpatient Hospital
21 (8717)
21 (8717)
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 (3006140)
14631-6 (3006140)
Infraclavicular plexus blockade
WX203 (2001310779)
WX203 (2001310779)
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 (3012336)
4542-7 (3012336)
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 (3003338)
28540-3 (3003338)
Supine thorax X-ray examination
GD1QA (2001303648)
GD1QA (2001303648)
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 (40771025)
68438-1 (40771025)
Catheterisation of bladder
TKC20 (2001306020)
TKC20 (2001306020)
Bacteria identified in Skin by Aerobe culture
620-5 (3007853)
620-5 (3007853)
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 (3030366)
33863-2 (3030366)
Creatinine [Moles/volume] in Serum or Plasma
14682-9 (3020564)
14682-9 (3020564)
Leukocytes [#/volume] in Urine
30405-5 (3018095)
30405-5 (3018095)
Supraclavicular plexus blockade
WX202 (2001310778)
WX202 (2001310778)
sulfamethoxazole and trimethoprim
J01EE01 (21602961)
J01EE01 (21602961)
INR in Blood by Coagulation assay
34714-6 (3032080)
34714-6 (3032080)
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 (3044938)
34487-9 (3044938)
Urinary tract ultrasound examination
KH1AE (2001306329)
KH1AE (2001306329)
temazepam; oral
N05CD07 (21604642)
N05CD07 (21604642)
Type 1 diabetes mellitus, With multiple complications
E10.7 (45571655)
E10.7 (45571655)
Respiratory and circulatory monitoring
WX700 (2001310817)
WX700 (2001310817)
Platelets [#/volume] in Blood
26515-7 (3007461)
26515-7 (3007461)
Leukocytes [#/volume] in Blood
26464-8 (3010813)
26464-8 (3010813)
MCH [Entitic mass]
28539-5 (3035941)
28539-5 (3035941)
MCV [Entitic mean volume] in Red Blood Cells
30428-7 (3024731)
30428-7 (3024731)
Erythrocytes [#/volume] in Blood
26453-1 (3026361)
26453-1 (3026361)
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 (3009542)
20570-8 (3009542)
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 (3016417)
1805-1 (3016417)
Hemoglobin [Mass/volume] in Blood
718-7 (3000963)
718-7 (3000963)
diazepam; oral, parenteral, rectal
N05BA01 (21604566)
N05BA01 (21604566)
Pneumonia, unspecified
J18.9 (45601123)
J18.9 (45601123)
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 (3006923)
1742-6 (3006923)
Blood type and Crossmatch panel - Blood
34531-4 (3044640)
34531-4 (3044640)
Prothrombin time (PT) actual/Normal
5894-1 (3033658)
5894-1 (3033658)
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 (3023465)
2874-6 (3023465)
Oxygen [Partial pressure] in Venous blood
2705-2 (3024354)
2705-2 (3024354)
Emergency Room Visit
ER (9203)
ER (9203)
Biopsy of skin and subcutaneous tissue
TQX10 (2001310152)
TQX10 (2001310152)
oxycodone; oral, parenteral
N02AA05 (21604260)
N02AA05 (21604260)
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46083-2 (3043362)
46083-2 (3043362)
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46082-4 (3046524)
46082-4 (3046524)
Cathetrisation of artery
TPH07 (2001309747)
TPH07 (2001309747)
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 (3029287)
50554-5 (3029287)
clopidogrel; oral
B01AC04 (21600989)
B01AC04 (21600989)
Intensive care
WX872 (2001310844)
WX872 (2001310844)
Pulmonary Disease
29 (38004472)
29 (38004472)
lactulose; oral
A06AD11 (21600571)
A06AD11 (21600571)
Implantation of vascular injection port
TPX10 (2001309608)
TPX10 (2001309608)
Potassium [Moles/volume] in Serum or Plasma
2823-3 (3023103)
2823-3 (3023103)
potassium chloride; oral
A12BA01 (21600877)
A12BA01 (21600877)
Sodium [Moles/volume] in Serum or Plasma
2951-2 (3019550)
2951-2 (3019550)
ECG with 12 standard connections
XF400 (2001303368)
XF400 (2001303368)
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 (3013721)
1920-8 (3013721)
Foot and toes X-ray examination
NH3AA (2001308267)
NH3AA (2001308267)
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 (3029379)
50797-0 (3029379)
Blood group antibody screen [Presence] in Serum or Plasma
890-4 (3001079)
890-4 (3001079)
Osmolality of Urine
2695-5 (3026782)
2695-5 (3026782)
magnesium hydroxide; oral
A02AA04 (21600052)
A02AA04 (21600052)
magnesium hydroxide; oral
G04BX01 (21602658)
G04BX01 (21602658)
Other disorders resulting from impaired renal tubular function
N25.8 (45582397)
N25.8 (45582397)
X-ray mammography
HA1AA (2001303884)
HA1AA (2001303884)
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 (3029338)
50796-2 (3029338)
Written specialist consultation based on a referral from a dentist or a physician
WZC10 (2001310887)
WZC10 (2001310887)
clindamycin; oral, parenteral
J01FF01 (21602985)
J01FF01 (21602985)
Caries of cementum
K02.2 (45591568)
K02.2 (45591568)
Pelvis X-ray examination
NE1AA (2001307792)
NE1AA (2001307792)
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA (2001301913)
EB1HA (2001301913)
Chronic ulcer skin
S97 (2002001061)
S97 (2002001061)
Deposits [accretions] on teeth betel
K03.65 (2000502690)
K03.65 (2000502690)
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 (3035797)
35559-4 (3035797)
zopiclone; oral
N05CF01 (21604654)
N05CF01 (21604654)
Casts [#/volume] in Urine by Automated count
51483-6 (3030467)
51483-6 (3030467)
Ultrasound examination of lower leg veins
PH2AE (2001309451)
PH2AE (2001309451)
Icteric interference index of Serum or Plasma
46426-3 (3051651)
46426-3 (3051651)
Person consulting for explanation of investigation findings
Z71.2 (45552100)
Z71.2 (45552100)
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 (3012110)
2589-0 (3012110)
Tacrolimus [Mass/volume] in Blood
11253-2 (3026250)
11253-2 (3026250)
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 (3019284)
5195-3 (3019284)
PEEP
WX722 (2001310825)
WX722 (2001310825)
Epstein Barr virus Ab [Presence] in Serum
49178-7 (3048929)
49178-7 (3048929)
Urinalysis macro (dipstick) panel - Urine
24357-6 (3037467)
24357-6 (3037467)
Ileoscopy through colon
UJF30 (2001305028)
UJF30 (2001305028)
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 (3029713)
51435-6 (3029713)
tramadol; oral, parenteral, rectal
N02AX02 (21604298)
N02AX02 (21604298)
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 (3005895)
2639-3 (3005895)
More than five and less than seven hours
ZXE30 (2001311411)
ZXE30 (2001311411)
Treponema pallidum Ab [Presence] in Serum
22587-0 (3019832)
22587-0 (3019832)
Intraoperative use of conventional X-ray imaging
ZXM10 (2001311446)
ZXM10 (2001311446)
Other dialysis
Z49.2 (45576160)
Z49.2 (45576160)
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 (3016293)
1963-8 (3016293)
Rheumatology
66 (38004491)
66 (38004491)
Repeated or continuing anesthesia shots throug a catheter
WX602 (2001310813)
WX602 (2001310813)
Urate [Moles/volume] in Serum or Plasma
14933-6 (3026493)
14933-6 (3026493)
Body CT examination
JN4AD (2001310897)
JN4AD (2001310897)
Ultrasound examination of mammary glands
HA1AE (2001303886)
HA1AE (2001303886)
Telehealth
OMOP5556618 (722455)
OMOP5556618 (722455)
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 (3023024)
2020-6 (3023024)
Lipemic interference index of Serum or Plasma
46425-5 (3051611)
46425-5 (3051611)
Ambulatory ECG
XF404 (2001303370)
XF404 (2001303370)
Hyaline casts [#/volume] in Urine by Automated count
51484-4 (3030981)
51484-4 (3030981)
Bilateral
ZXA10 (2001311348)
ZXA10 (2001311348)
IgG [Mass/volume] in Serum or Plasma
2465-3 (3005719)
2465-3 (3005719)
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 (3013742)
14338-8 (3013742)
Case Management Agency
251B00000X (38004193)
251B00000X (38004193)
Hepatitis B virus surface Ab [Units/volume] in Serum
16935-9 (3023421)
16935-9 (3023421)
Bacteria [Presence] in Urine
87829-8 (36304419)
87829-8 (36304419)
moxifloxacin; oral, parenteral
J01MA14 (21603021)
J01MA14 (21603021)
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E11.2 (2000503133)
N08.39*E11.2 (2000503133)
Cathetrisation of vein
TPH04 (2001309597)
TPH04 (2001309597)
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 (3000515)
27811-9 (3000515)
Atrial fibrillation and flutter
I48 (45596206)
I48 (45596206)
Laboratory Visit
OMOP4822461 (32036)
OMOP4822461 (32036)
pregabalin; oral
N02BF02 (955152)
N02BF02 (955152)
IgM [Mass/volume] in Serum or Plasma
2472-9 (3028026)
2472-9 (3028026)
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 (3016407)
3255-7 (3016407)
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 (3019250)
3209-4 (3019250)
ciprofloxacin; oral, parenteral
J01MA02 (21603009)
J01MA02 (21603009)
Protein [Mass/time] in 24 hour Urine
2889-4 (3020876)
2889-4 (3020876)
Obstetrics / Gynecology
16 (38004461)
16 (38004461)
isosorbide mononitrate; oral
C01DA14 (21600324)
C01DA14 (21600324)
Thoracic and Cardiac Surgery
OMOP4822009 (45756830)
OMOP4822009 (45756830)
General Surgery
2 (38004447)
2 (38004447)
Dental examination
Z01.2 (45581002)
Z01.2 (45581002)
Upper gastrointestinal surgery
106 (44777669)
106 (44777669)
Chronic disorders of vitamin D metabolism
123 (2001600122)
123 (2001600122)
Hand and fingers X-ray examination
ND2AA (2001307607)
ND2AA (2001307607)
Pharmacy visit
OMOP4822462 (581458)
OMOP4822462 (581458)
Campylobacter sp identified in Tissue by Organism specific culture
20740-7 (3006418)
20740-7 (3006418)
Essential (primary) hypertension
I10 (45591453)
I10 (45591453)
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 (3011960)
30934-4 (3011960)
Thrombin time
3243-3 (3036489)
3243-3 (3036489)
Gingivitis (chronic) ulcerative
K05.19 (2000502722)
K05.19 (2000502722)
Extensive abdominal CT
JN3BD (2001305556)
JN3BD (2001305556)
Shigella sp [Presence] in Stool by Culture
82300-5 (42529406)
82300-5 (42529406)
Neck ultrasound examination
EP1AE (2001302284)
EP1AE (2001302284)
Yersinia sp identified in Stool by Organism specific culture
28549-4 (3014765)
28549-4 (3014765)
pH of Capillary blood
2745-8 (3009343)
2745-8 (3009343)
Chloride [Moles/volume] in Serum or Plasma
2075-0 (3014576)
2075-0 (3014576)
Gas panel - Capillary blood
24337-8 (3022313)
24337-8 (3022313)
Other specified counselling
Z71.8 (45581061)
Z71.8 (45581061)
levofloxacin; inhalant, oral, parenteral
J01MA12 (21603019)
J01MA12 (21603019)
allopurinol; oral, parenteral
M04AA01 (21604131)
M04AA01 (21604131)
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 (3043849)
43730-1 (3043849)
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 (3005772)
29760-6 (3005772)
Optical coherence tomography (OCT) of ocular fundus
CK2X4 (2001301456)
CK2X4 (2001301456)
Fever, unspecified
R50.9 (45582716)
R50.9 (45582716)
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 (43055554)
72720-6 (43055554)
cefalexin; oral
J01DB01 (21602870)
J01DB01 (21602870)
Protein [Mass/volume] in Serum or Plasma
2885-2 (3020630)
2885-2 (3020630)
Bacteria [#/volume] in Urine by Automated count
51480-2 (3031040)
51480-2 (3031040)
pantoprazole; oral, parenteral
A02BC02 (21600097)
A02BC02 (21600097)
Lactate [Moles/volume] in Serum or Plasma
2524-7 (3014111)
2524-7 (3014111)
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 (43054903)
72160-5 (43054903)
Inpatient Visit
IP (9201)
IP (9201)
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 (3019902)
13317-3 (3019902)
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 (3029187)
33762-6 (3029187)
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE (2001306544)
LC2BE (2001306544)
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 (3015635)
7853-5 (3015635)
Midwife
Z3232 (2001311563)
Z3232 (2001311563)
TACROLIMUS - yes
TACROLIMUS-1 (2002330222)
TACROLIMUS-1 (2002330222)
prednisolone; oral, parenteral
H02AB06 (21602734)
H02AB06 (21602734)
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 (3017918)
22246-3 (3017918)
prednisolone
A07EA01 (21600653)
A07EA01 (21600653)
CD3+CD4+ (T4 helper) cells/cells in Blood
8123-2 (3014037)
8123-2 (3014037)
General Practice
1 (38004446)
1 (38004446)
CBC panel - Blood by Automated count
58410-2 (40761511)
58410-2 (40761511)
cloZAPine [Moles/volume] in Serum or Plasma
14656-3 (3000081)
14656-3 (3000081)
Varicella zoster virus Ab [Titer] in Serum
21594-7 (3014148)
21594-7 (3014148)
Urology
34 (38004474)
34 (38004474)
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 (3043924)
40987-0 (3043924)
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24467-3 (3028167)
24467-3 (3028167)
Differential panel, method unspecified - Blood
69738-3 (42870588)
69738-3 (42870588)
tiotropium bromide; inhalant
R03BB04 (21603296)
R03BB04 (21603296)
Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
29662-4 (3012220)
29662-4 (3012220)
Immunohistochemistry procedure
117617002 (4035726)
117617002 (4035726)
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 (3007220)
2157-6 (3007220)
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 (3013707)
4537-7 (3013707)
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 (3038288)
40982-1 (3038288)
amoxicillin; oral, parenteral
J01CA04 (21602823)
J01CA04 (21602823)
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 (3010130)
7852-7 (3010130)
Bacteria identified in Urine by Culture
630-4 (3026008)
630-4 (3026008)
Care involving use of other rehabilitation procedures
Z50.8 (45556842)
Z50.8 (45556842)
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 (2001304788)
UJD10 (2001304788)
CD4 cells/Lymphocytes in Specimen
80223-1 (21494815)
80223-1 (21494815)
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 (2001310246)
R5110 (2001310246)
Creatinine [Moles/volume] in Urine
14683-7 (3009508)
14683-7 (3009508)
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 (3016771)
1798-8 (3016771)
bisoprolol; oral
C07AB07 (21601689)
C07AB07 (21601689)
Magnesium Ionized [Moles/volume] in Serum or Plasma
2600-5 (3021197)
2600-5 (3021197)
Influenza virus A+B Ag [Presence] in Specimen
24015-0 (3024891)
24015-0 (3024891)
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 (3020059)
29265-6 (3020059)
IgA [Mass/volume] in Serum or Plasma
2458-8 (3007164)
2458-8 (3007164)
Other gastroenteritis and colitis of infectious and unspecified origin
A09 (45605189)
A09 (45605189)
Medical observation and evaluation for suspected diseases and conditions, ruled out
Z03 (45552058)
Z03 (45552058)
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 (3004410)
4548-4 (3004410)
Salmonella sp identified in Stool by Organism specific culture
20955-1 (3004716)
20955-1 (3004716)
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 (3007080)
31374-2 (3007080)
doxycycline; oral, parenteral
J01AA02 (21602800)
J01AA02 (21602800)
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 (3007844)
5159-9 (3007844)
cetirizine; oral
R06AE07 (21603497)
R06AE07 (21603497)
Albumin [Mass/volume] in Urine
1754-1 (3012516)
1754-1 (3012516)
Tissue Pathology biopsy report
66121-5 (40768804)
66121-5 (40768804)
Procedure duration 50 to 59 minutes
ZXE06 (2001311400)
ZXE06 (2001311400)
Procedure duration 90 to 119 minutes
ZXE13 (2001311404)
ZXE13 (2001311404)
Acute bronchitis, unspecified
J20.9 (45562445)
J20.9 (45562445)
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
190 (2001600189)
190 (2001600189)
BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
32284-2 (3000504)
32284-2 (3000504)
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 (3014218)
19230-2 (3014218)
Fungus identified in Specimen by Culture
580-1 (3000494)
580-1 (3000494)
Folate [Moles/volume] in Red Blood Cells
14731-4 (3019309)
14731-4 (3019309)
HLA Ab [Presence] in Serum
44534-6 (3042733)
44534-6 (3042733)
Ultrasound examination transplanted kidney
KA2AE (2001305644)
KA2AE (2001305644)
Procedure duration 10 to 19 minutes
ZXE02 (2001311396)
ZXE02 (2001311396)
amlodipine; oral
C08CA01 (21601747)
C08CA01 (21601747)
Remote contact by phone
ZYC01 (2001311579)
ZYC01 (2001311579)
General anaesthesia
WX402 (2001310806)
WX402 (2001310806)
Pathology report gross observation
24419-4 (3002256)
24419-4 (3002256)
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 (3029879)
51486-9 (3029879)
Monitoring the use of the aid
R5140 (2001310249)
R5140 (2001310249)
methoxy polyethylene glycol-epoetin beta; parenteral
B03XA03 (21601135)
B03XA03 (21601135)
Lipid panel - Serum or Plasma
100898-6 (1761868)
100898-6 (1761868)
Teaching
WZC30 (2001310891)
WZC30 (2001310891)
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 (3051714)
48065-7 (3051714)
T2D - yes
T2D-2 (2002330230)
T2D-2 (2002330230)
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 (3023602)
14646-4 (3023602)
Kidney Pathology biopsy report
65757-7 (40768446)
65757-7 (40768446)
Laceration/cut
S18 (2002000983)
S18 (2002000983)
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 (3019900)
14647-2 (3019900)
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 (3030306)
51485-1 (3030306)
Human papilloma virus identified in Specimen
11481-9 (3025130)
11481-9 (3025130)
Paranasal sinuses X-ray examination without contrast
DM1AA (2001301740)
DM1AA (2001301740)
Allogenic transplantation of kidney from cadaver donor
KAS10 (2001305738)
KAS10 (2001305738)
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 (3048773)
47210-0 (3048773)
Photography of skin or subcutaneous tissue in lower extremities, unspecified
QD9S1 (2001310014)
QD9S1 (2001310014)
Transplant complication
127 (2001600125)
127 (2001600125)
Other psychiatric pharmacotherapy service
IFA99 (2001304299)
IFA99 (2001304299)
HLA-A [Type]
13298-5 (3024471)
13298-5 (3024471)
HLA-DR beta [Type]
13306-6 (3024932)
13306-6 (3024932)
cycloSPORINE [Mass/volume] in Blood
3520-4 (3010375)
3520-4 (3010375)
Herpes simplex virus Ag [Presence] in Specimen
16945-8 (3001964)
16945-8 (3001964)
Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9654-5 (3007847)
9654-5 (3007847)
Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
40724-7 (3040363)
40724-7 (3040363)
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
216
34
89.70
307.65
19.7
5.9
860.24
107.63
u/ml
—
130
8
218
41
75.30
307.65
2.9
2.6
31.85
42.41
%
2.70
61
22
467
871
13.05
281.75
31.5
6.5
1.11
1.04
mmol/l
3.85
461
813
252
227
16.40
253.85
8.9
4.8
246.85
384.81
mg/l
0.83
241
102
350
626
9.80
209.91
3.6
2.7
30.70
117.49
u/l
0.59
330
533
182
180
13.13
169.34
5.3
3.1
2.58
2.28
index
0.14
116
110
474
1653
6.30
133.23
9.3
4.3
91.96
90.32
%
0.66
467
1628
567
2359
7.23
128.86
11.5
4.0
66.76
81.05
e6/l
0.24
368
1657
654
3132
11.21
126.81
20.2
6.7
56.34
56.98
%
0.67
640
3008
76
19
44.52
126.61
2.9
3.0
0.61
0.60
mmol/l
0.13
76
19
357
1026
5.84
123.63
5.3
3.1
1.91
1.90
e6/l
0.00
179
497
652
3172
10.66
122.29
20.4
6.9
28.70
27.76
%
1.24
641
3032
614
2890
7.98
116.96
23.3
11.2
0.00
0.00
e9/l
0.37
541
2336
592
2764
6.97
111.57
16.6
5.5
36.75
36.07
g/l
2.27
578
2610
254
594
6.02
109.22
30.4
8.9
14.19
9.04
mmol/l
20.81
246
568
118
115
12.04
109.18
1.5
1.3
—
—
—
0
0
118
115
12.04
109.18
1.5
1.3
—
—
—
0
0
658
3430
10.08
108.13
20.1
6.8
1.91
1.93
e9/l
0.13
618
3035
661
3474
10.31
107.24
20.6
7.0
0.20
0.20
e9/l
0.25
619
3049
354
1126
5.15
105.72
5.3
2.9
0.58
1.10
e6/l
2.31
175
595
272
696
5.63
105.33
20.2
3.8
1.30
1.70
mmol/l
1.02
247
597
269
721
5.32
97.84
20.2
3.8
5.99
5.79
kpa
2.10
264
703
670
3730
10.40
97.05
26.1
10.0
3.90
4.10
e9/l
1.66
627
3257
445
1783
4.82
96.87
8.4
3.2
0.20
0.41
e6/l
2.40
344
1304
160
276
7.14
92.95
3.1
1.9
1.41
1.49
g/l
0.49
153
248
117
152
8.97
87.01
13.0
6.5
672.20
369.19
iu/ml
0.57
30
21
50
10
53.59
86.99
3.5
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
130
194
7.93
85.97
6.0
3.1
0.29
0.35
iu/ml
0.64
53
102
467
2067
4.48
85.76
9.4
3.4
28.57
81.52
e6/l
0.96
365
1578
292
935
4.53
83.20
11.8
2.6
22.67
23.54
%
0.58
287
888
85
5
191.94
83.07
15.9
3.8
5.13
5.98
mmol/l
—
85
5
111
143
8.97
83.00
2.7
1.5
155.00
154.87
au/ml
0.00
53
43
307
1073
4.21
76.68
11.0
2.6
12.32
13.68
umol/l
3.09
298
1012
605
3421
5.43
75.61
12.1
7.0
10.85
11.95
umol/l
1.89
594
3276
295
1014
4.20
75.19
11.1
2.6
2.11
2.32
g/l
8.02
284
948
137
251
6.48
74.27
2.3
1.3
—
—
—
0
0
214
618
4.48
68.28
8.5
3.3
6.55
4.56
kpa
7.81
206
603
317
1212
3.85
68.18
6.5
4.0
182.24
476.18
ng/l
1.95
270
942
105
159
7.54
68.02
1.7
1.3
223.39
254.61
u/ml
0.45
77
93
293
1091
3.81
65.03
8.7
3.9
0.81
0.82
mmol/l
0.57
283
1042
78
88
9.80
64.28
2.3
2.3
49.07
64.41
iu/ml
—
7
8
331
1403
3.48
59.02
8.0
2.7
3.94
4.68
e6/l
0.51
305
1286
611
3822
4.62
58.09
16.3
5.5
6.62
6.70
mmol/l
0.42
601
3648
45
24
19.91
57.43
1.1
1.0
—
—
—
0
0
74
92
8.84
56.44
7.4
6.1
10.83
10.62
mg/l
0.13
67
86
696
4892
9.60
55.32
21.9
8.4
85.41
80.22
u/l
2.06
683
4670
144
370
4.60
52.42
2.4
1.6
—
—
—
0
0
342
1586
3.17
50.79
5.3
2.5
—
—
—
0
0
43
27
16.86
50.72
32.7
42.9
119.23
113.23
ug/l
0.15
30
22
54
51
11.35
50.26
6.0
3.8
0.52
0.86
index
2.37
54
51
268
1084
3.32
50.10
3.2
1.9
—
—
—
0
0
217
771
3.58
49.92
2.9
1.8
—
—
—
0
0
59
67
9.49
48.15
5.9
3.7
15.04
12.88
index
0.71
54
51
221
820
3.43
47.18
2.9
1.8
—
—
—
0
0
63
89
7.65
43.00
1.2
1.1
—
—
—
0
0
95
204
5.20
42.60
2.9
2.5
9.88
10.53
g/l
0.69
90
186
209
794
3.28
42.42
3.9
3.1
5.98
8.08
umol/l
1.18
188
719
100
227
4.94
42.01
3.1
2.4
2.93
2.96
g/l
0.08
95
210
143
442
3.78
39.86
3.6
3.1
542.49
186.98
ng/l
2.58
137
403
100
238
4.71
39.60
3.1
2.4
3.52
3.84
g/l
1.06
95
221
100
238
4.71
39.60
3.1
2.4
3.96
4.27
g/l
2.02
95
221
100
238
4.71
39.60
3.1
2.4
7.37
7.21
g/l
0.41
95
221
503
3176
2.87
38.35
38.8
7.9
1.20
1.21
mmol/l
1.62
486
2778
37
30
12.94
37.78
9.2
1.8
345.14
97.22
ng/l
5.01
37
30
466
2845
2.76
37.68
29.5
7.3
1.20
1.21
mmol/l
1.18
450
2648
99
243
4.55
37.67
3.1
2.6
93.85
93.36
%
0.07
99
237
460
2804
2.72
37.08
4.7
2.5
76.02
75.50
nmol/l
0.14
436
2549
155
543
3.35
35.36
13.5
2.8
65.09
70.14
e9/l
1.14
87
405
697
5465
6.76
34.95
70.6
19.8
330.98
333.58
g/l
9.88
697
5445
58
96
6.48
34.11
1.6
1.4
—
—
—
0
0
89
218
4.51
33.86
1.1
1.3
99.95
205.55
miu/ml
2.10
20
103
167
627
3.16
33.85
2.8
2.5
0.24
0.21
g/l
4.17
156
583
137
456
3.47
33.82
2.1
1.6
—
—
—
0
0
47
64
7.78
33.00
1.0
1.0
—
—
—
0
0
505
3337
2.66
32.70
6.4
3.7
0.00
0.00
estimate
0.50
33
667
43
56
8.10
31.33
1.9
1.6
—
—
—
0
0
35
35
10.45
31.15
4.6
3.5
773.51
625.43
u/ml
0.37
35
35
505
3379
2.59
31.13
6.4
3.7
35.84
2.41
estimate
0.45
37
675
506
3392
2.59
31.02
6.4
3.8
0.00
0.51
estimate
0.53
32
616
386
2313
2.41
29.92
9.0
3.6
7.42
8.23
mmol/l
2.57
360
1983
155
597
3.03
29.76
4.0
3.4
—
—
—
0
0
82
208
4.31
29.73
2.8
2.7
0.41
1.02
g/l
1.04
77
187
101
303
3.71
29.00
6.4
1.9
—
—
—
0
0
113
370
3.43
28.38
6.0
2.0
—
—
—
0
0
41
59
7.30
27.39
5.1
4.1
—
—
—
0
0
422
2713
2.31
26.71
2.5
2.0
91.44
95.95
pmol/l
1.30
201
1472
444
2960
2.27
25.15
10.0
3.0
195.75
139.28
ug/l
3.46
432
2783
284
1588
2.29
24.60
5.3
2.2
2.18
2.87
mg/l
7.14
256
1383
72
192
4.05
24.33
1.5
1.2
—
—
—
0
0
170
774
2.56
23.19
12.7
9.9
5.12
5.10
kpa
0.10
164
748
170
775
2.55
23.12
12.7
9.8
11.56
12.40
kpa
1.45
164
752
167
760
2.55
22.76
12.6
10.0
-0.98
0.88
mmol/l
5.57
146
639
414
2754
2.16
22.64
2.6
2.0
1.45
1.43
mmol/l
0.25
398
2361
254
1398
2.25
22.46
2.2
1.4
2.17
2.55
g/l
2.42
133
872
55
132
4.42
21.32
2.3
1.4
—
—
—
0
0
121
497
2.72
20.12
2.8
2.7
63.63
67.00
g/l
4.65
115
465
123
511
2.69
20.00
4.1
2.6
64.31
69.73
ml/min/173m2
0.45
34
219
290
1745
2.10
19.94
1.9
1.7
19.81
20.15
nmol/l
0.17
256
1499
421
2912
2.05
19.64
28.3
12.9
1.30
1.22
inr
2.07
350
2383
703
6071
4.99
19.43
47.7
14.6
72.40
84.02
ml/min/173m2
16.69
691
5611
63
179
3.76
19.43
4.1
3.2
1.44
2.59
ratio
1.26
39
98
72
233
3.32
18.21
2.4
1.6
—
—
—
0
0
592
4725
2.32
18.06
7.1
4.2
15.33
10.93
mm/h
7.49
571
4443
284
1747
2.02
17.96
6.7
2.8
382.77
350.95
umol/l
5.67
269
1572
715
6321
6.65
17.63
49.6
15.4
25.64
23.90
mg/l
0.93
637
5180
107
443
2.66
17.41
8.3
3.2
114.18
132.22
g/l
11.42
107
433
29
47
6.38
17.31
2.1
2.2
760.04
496.15
e6/l
1.32
24
39
121
535
2.51
17.19
3.2
2.5
10.41
7.96
ug/l
0.29
101
488
211
1183
2.10
17.03
4.8
3.0
2.47
2.45
mmol/l
1.55
188
1069
54
152
3.76
16.86
1.8
1.4
—
—
—
0
0
97
390
2.71
16.70
7.7
2.6
0.55
0.62
%
1.79
97
390
46
117
4.13
16.52
1.6
1.3
2.76
5.05
u/ml
0.51
17
39
40
94
4.44
15.90
2.4
1.4
—
—
—
0
0
83
1822
0.39
15.55
6.8
3.9
0.00
0.01
estimate
1.15
33
618
244
1498
1.94
14.96
2.4
1.8
1.46
1.22
mg/l
0.48
193
1173
305
2017
1.88
14.88
3.2
2.2
168.69
267.59
u/l
1.24
299
1926
174
951
2.09
14.78
1.7
1.7
762.42
1189.25
nmol/l
11.25
131
747
22
33
6.84
14.09
1.3
1.7
—
—
—
0
0
22
33
6.84
14.09
1.3
1.7
—
—
—
0
0
43
117
3.84
14.09
1.7
1.3
5.35
3.94
u/ml
0.24
20
54
314
2127
1.83
13.95
9.0
3.6
156.88
59.10
mg/l
3.49
261
1392
153
2538
0.50
13.16
5.3
3.6
0.00
0.02
estimate
1.22
29
564
128
653
2.16
12.87
15.7
10.9
111.27
123.29
g/l
9.27
128
642
63
232
2.88
12.74
5.2
1.9
—
—
—
0
0
678
6004
2.75
12.30
12.6
6.3
38.72
39.30
mmol/mol
0.72
664
5684
23
42
5.62
12.18
2.1
2.1
—
—
—
0
0
53
185
3.01
11.79
1.3
1.1
—
—
—
0
0
53
186
2.99
11.68
1.3
1.1
—
—
—
0
0
516
4176
1.80
11.57
4.0
3.1
—
—
—
0
0
394
2961
1.72
11.46
5.0
2.9
—
—
estimate
—
0
0
57
211
2.85
11.42
5.6
1.8
—
—
—
0
0
74
316
2.49
11.19
1.7
1.4
—
—
—
0
0
306
2160
1.72
11.10
9.6
4.3
34.41
9.97
mg/mmol
4.53
244
1368
268
1828
1.74
10.98
4.7
3.3
7593.34
1180.94
ng/l
6.07
248
1537
19
16
12.16
10.88
8.0
8.8
10.54
4.81
kpa
6.01
19
16
23
47
5.02
10.79
1.1
1.0
—
—
—
0
0
25
57
4.51
10.33
1.6
1.4
26430.13
25476.72
e6/l
0.02
16
29
673
6034
2.43
10.16
7.2
4.3
1.41
1.35
mmol/l
1.29
655
5634
721
6716
5.89
10.04
32.0
11.9
27.22
28.52
u/l
1.42
715
6565
296
2114
1.67
10.00
7.2
3.6
2.35
2.36
mmol/l
0.27
271
1936
26
64
4.18
9.77
1.8
1.6
—
—
—
0
0
50
189
2.77
9.65
2.4
1.5
—
—
—
0
0
22
49
4.60
9.36
2.0
3.0
1614.55
1188.65
mg
0.32
22
49
726
6942
6.59
9.10
76.1
23.3
4.31
4.58
e12/l
27.71
720
6817
21
31
6.94
8.89
1.3
1.7
2.53
2.01
umol/l
1.29
21
26
21
47
4.57
8.88
1.2
2.3
209.60
206.68
e6/l
0.02
15
41
21
708
0.28
8.84
7.1
7.0
—
—
—
0
0
134
791
1.85
8.72
5.1
2.0
—
—
—
0
0
14
10
14.24
8.71
4.4
1.2
92.29
96.40
%
—
14
10
27
785
0.32
8.61
5.0
4.7
33.00
31.04
%
0.46
17
536
697
6431
2.75
8.44
61.4
18.3
4.03
3.98
mmol/l
3.26
690
6323
124
723
1.86
8.37
4.7
1.9
—
—
—
0
0
69
329
2.21
8.13
1.5
1.3
—
—
—
0
0
688
6328
2.45
8.05
8.6
5.1
4.38
4.64
mmol/l
9.58
674
5969
24
65
3.78
7.96
1.6
1.4
913.33
2053.98
e6/l
1.65
15
43
20
33
6.20
7.89
1.5
2.0
—
—
—
0
0
20
33
6.20
7.89
1.5
2.0
—
—
—
0
0
20
33
6.20
7.89
1.5
2.0
—
—
—
0
0
20
33
6.20
7.89
1.5
2.0
—
—
—
0
0
32
107
3.08
7.70
1.1
1.2
118.72
114.52
%
0.29
32
100
685
6310
2.33
7.61
8.6
5.0
1.34
1.41
mmol/l
5.07
671
5923
13
11
12.01
7.60
5.5
5.6
2.02
2.66
mg/l
0.37
13
11
73
366
2.10
7.58
1.8
1.8
0.28
0.34
mg/l
0.51
37
178
50
214
2.43
7.55
1.3
1.3
—
—
—
0
0
21
54
3.97
7.47
1.2
1.1
—
—
—
0
0
33
115
2.96
7.41
1.1
1.1
—
—
—
0
0
692
6414
2.44
7.37
9.3
5.7
2.57
2.74
mmol/l
5.83
674
6027
21
55
3.90
7.29
1.2
1.1
—
—
—
0
0
118
1846
0.57
7.23
4.6
3.2
0.00
0.06
estimate
0.63
28
544
24
70
3.51
7.17
1.2
1.2
—
—
—
0
0
21
56
3.83
7.12
1.2
1.1
—
—
—
0
0
21
56
3.83
7.12
1.2
1.1
—
—
—
0
0
10
6
16.88
6.76
2.2
1.3
—
—
—
0
0
45
198
2.36
6.42
2.5
1.6
—
—
—
0
0
71
1247
0.52
6.38
1.5
1.7
489.31
19677237.14
pmol/l
0.92
65
1052
50
232
2.24
6.31
2.1
2.8
—
—
—
0
0
28
98
2.93
6.27
2.7
1.5
—
—
—
0
0
93
1498
0.57
6.19
7.9
3.8
1.02
1.02
kg/l
0.89
66
982
21
62
3.46
6.18
1.2
1.1
—
—
—
0
0
22
67
3.35
6.18
1.2
1.2
—
—
—
0
0
39
167
2.41
5.92
2.4
1.6
17898.85
10511.07
e6/l
0.73
20
121
21
64
3.35
5.90
1.5
1.7
—
—
—
0
0
21
64
3.35
5.90
1.5
1.7
—
—
—
0
0
21
64
3.35
5.90
1.5
1.7
—
—
—
0
0
59
301
2.04
5.87
39.7
3.4
23.74
25.09
mmol/l
2.41
59
293
40
174
2.37
5.87
1.5
1.7
—
—
—
0
0
10
409
0.23
5.83
3.4
8.3
24.11
24.48
mmol/l
—
10
393
23
75
3.13
5.81
1.3
1.2
—
—
—
0
0
25
86
2.97
5.78
1.1
1.1
93.12
98.05
%
0.36
25
80
47
221
2.20
5.76
1.2
1.5
0.08
0.06
iu/ml
0.13
12
36
43
197
2.26
5.62
1.5
1.5
230.13
293.76
ug/g
1.30
36
117
40
816
0.46
5.57
1.4
2.0
3.44
3.70
ratio
0.79
29
661
17
47
3.68
5.51
1.0
1.1
16.68
6.54
iu/ml
—
5
15
210
1550
1.50
5.46
1.3
1.3
0.74
1.21
u/ml
1.15
18
432
15
29
5.26
5.41
3.3
1.7
136.60
74.47
ug/l
0.48
15
29
263
2040
1.45
5.29
6.1
2.8
64.58
64.71
u/l
0.01
257
1930
31
127
2.50
5.19
2.7
1.8
—
—
—
0
0
24
87
2.82
5.08
1.5
1.3
—
—
—
0
0
24
88
2.79
4.98
1.5
1.4
—
—
—
0
0
24
88
2.79
4.98
1.5
1.4
—
—
—
0
0
188
2467
0.68
4.88
4.5
3.7
110.66
62.81
ng/l
0.35
124
1734
6
254
0.23
4.86
1.2
1.7
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
13
26
5.07
4.64
2.5
1.5
201.46
149.65
%
0.96
13
26
12
22
5.53
4.61
1.7
1.4
—
—
—
0
0
14
32
4.44
4.45
7.4
3.1
63.21
73.92
mg/l
0.31
14
24
9
12
7.58
4.36
1.3
1.2
—
—
—
0
0
45
236
1.97
4.21
1.6
1.7
17.88
9.53
u/ml
—
8
58
8
10
8.07
4.07
1.8
1.8
—
—
—
0
0
32
150
2.19
4.02
1.5
1.6
—
—
—
0
0
68
414
1.71
3.96
10.5
4.4
2.16
1.68
mmol/l
0.46
40
306
34
165
2.11
3.92
1.2
1.2
—
—
—
0
0
14
43
3.30
3.92
2.1
3.6
103.86
99.49
%
0.17
14
43
51
287
1.84
3.88
2.4
2.0
16.15
7.90
iu/ml
—
6
72
10
19
5.32
3.83
1.4
1.8
—
—
—
0
0
30
592
0.49
3.81
1.3
1.7
3.38
3.53
mmol/l
0.23
18
429
27
122
2.26
3.71
1.0
1.1
—
2.12
—
0
8
32
157
2.09
3.61
2.1
1.4
—
—
—
0
0
7
10
7.05
3.37
1.0
1.1
—
—
—
0
0
14
48
2.95
3.31
1.9
1.2
—
—
—
0
0
13
43
3.06
3.26
1.2
1.2
—
—
—
0
0
45
260
1.78
3.18
1.9
2.0
3.84
4.35
mg/l
0.14
39
195
15
56
2.71
3.07
1.8
1.3
2.96
3.56
ug/l
0.28
15
48
7
12
5.88
3.02
1.3
1.3
1.14
1.17
mmol/l
—
7
12
506
4604
1.32
3.01
4.4
3.5
62.67
50.89
u/l
1.93
493
4377
12
37
3.28
2.94
4.3
1.6
—
—
—
0
0
5
6
8.38
2.75
1.4
2.2
—
—
—
0
0
5
6
8.38
2.75
1.6
1.5
90.60
40.00
umol/l
—
5
6
26
132
2.01
2.73
2.3
1.4
—
—
—
0
0
6
10
6.04
2.70
1.2
1.3
—
—
—
0
0
93
668
1.45
2.70
2.3
2.1
326.78
371.43
nmol/l
1.50
86
632
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
20
4.03
2.57
1.0
1.1
97.88
120.25
%
—
8
20
7
189
0.36
2.44
1.0
1.1
—
9.51
—
0
25
15
64
2.37
2.40
1.1
1.1
—
—
—
0
0
9
27
3.36
2.40
3.3
1.7
—
—
—
0
0
74
525
1.46
2.31
1.9
1.5
—
—
—
0
0
10
34
2.97
2.28
1.3
1.1
—
—
—
0
0
27
149
1.84
2.27
2.3
2.1
130.36
127.53
g/l
0.15
11
116
124
971
1.33
2.17
2.2
2.0
1.61
1.49
%
1.30
108
861
31
184
1.72
2.07
2.3
1.3
—
—
—
0
0
7
21
3.36
1.97
1.1
1.1
—
—
—
0
0
15
71
2.14
1.93
1.9
2.1
—
—
—
0
0
635
6083
1.33
1.88
7.9
5.0
6.10
5.98
mmol/l
1.14
607
5661
15
286
0.51
1.81
1.1
1.1
1.44
1.48
g/l
0.25
15
286
231
2633
0.82
1.71
4.4
4.9
15.13
2.11
ug/l
0.48
213
2406
16
82
1.97
1.70
1.9
2.0
—
—
—
0
0
16
291
0.54
1.68
5.7
6.7
1.82
1.61
%
0.18
16
277
7
25
2.82
1.65
1.0
1.2
—
—
—
0
0
16
84
1.92
1.60
1.4
1.4
—
—
—
0
0
16
84
1.92
1.60
1.4
1.4
—
—
—
0
0
16
85
1.90
1.56
1.4
1.4
—
—
—
0
0
13
66
1.99
1.44
1.2
1.0
309.23
278.10
mg/l
0.63
13
59
23
141
1.65
1.43
1.2
1.3
—
—
—
0
0
10
46
2.19
1.40
1.3
1.5
—
—
—
0
0
12
60
2.02
1.38
1.8
2.3
—
—
—
0
0
0
38
0.00
1.34
0.0
1.3
—
—
—
0
0
105
869
1.24
1.24
2.7
2.7
162.94
123.58
ug/g
0.51
89
718
599
5769
1.21
1.21
5.9
5.0
1.87
1.88
mu/l
0.12
568
5371
8
38
2.12
1.18
1.3
1.1
609.37
201.94
iu/ml
—
8
38
8
39
2.06
1.15
1.1
1.3
—
60.00
—
0
6
0
35
0.00
1.15
0.0
2.1
—
2.31
—
0
8
11
58
1.91
1.12
1.7
1.2
7.83
2.37
u/ml
0.39
11
33
78
632
1.26
1.12
4.7
4.7
5.78
17.28
ug/l
0.83
60
522
7
32
2.20
1.08
1.1
1.2
—
—
—
0
0
7
32
2.20
1.08
1.1
1.2
—
—
—
0
0
5
22
2.28
1.03
1.6
1.0
—
—
—
0
0
501
4778
1.15
1.03
4.4
4.1
14.08
14.76
pmol/l
8.74
478
4402
10
53
1.90
1.01
1.1
1.2
80.30
103.45
pmol/l
—
10
53
87
723
1.23
1.01
1.3
1.5
—
—
—
0
0
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
6
27
2.23
0.93
1.2
2.1
—
—
—
0
0
6
27
2.23
0.93
1.2
2.1
—
—
—
0
0
6
27
2.23
0.93
1.2
1.2
—
—
—
0
0
6
27
2.23
0.93
1.2
1.2
—
—
—
0
0
19
126
1.52
0.92
1.1
1.1
—
16.48
—
0
39
27
195
1.40
0.87
1.4
1.3
—
—
—
0
0
12
72
1.68
0.85
3.5
3.2
6.01
5.67
nmol/l
0.04
12
72
35
268
1.32
0.81
1.7
1.4
24.01
22.05
iu/l
0.13
28
219
26
350
0.73
0.80
12.7
3.8
50.51
49.29
%
0.08
26
345
19
132
1.45
0.76
1.2
1.3
—
430.00
—
0
10
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
8
132
0.60
0.74
2.5
1.5
—
—
—
0
0
9
55
1.64
0.73
13.1
1.6
—
—
—
0
0
6
106
0.56
0.73
3.0
1.5
—
—
—
0
0
22
295
0.74
0.68
1.5
1.1
0.91
0.90
g/l
0.02
22
295
21
156
1.36
0.61
2.1
1.3
15.06
14.15
e6/l
0.02
16
114
0
20
0.00
0.60
0.0
2.2
—
41.71
—
0
20
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
10
64
1.57
0.59
1.1
1.1
—
72.20
—
0
5
23
175
1.32
0.59
1.4
1.3
742.17
477.40
mg/l
0.62
23
167
197
2115
0.91
0.56
3.2
4.1
27.54
21.26
%
2.40
65
892
21
159
1.33
0.56
2.2
1.4
311.06
1369.08
e6/l
0.60
16
120
8
123
0.65
0.55
4.6
4.2
236.38
375.36
u/ml
—
8
116
24
186
1.30
0.55
2.5
2.4
854.46
5078.35
u/l
—
7
70
10
147
0.68
0.54
1.3
1.5
—
—
—
0
0
109
1196
0.90
0.47
1.4
1.3
34.23
29.34
iu/ml
0.11
31
381
31
257
1.22
0.43
2.5
3.0
30.54
44.03
u/ml
0.45
31
248
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
0.56
—
0
10
5
34
1.47
0.40
1.8
1.8
0.94
1.34
nmol/l
—
5
25
0
18
0.00
0.40
0.0
1.9
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
101
1099
0.91
0.39
1.4
1.3
6.68
10.28
u/ml
0.37
21
449
9
68
1.33
0.37
1.2
1.5
—
—
—
0
0
5
37
1.35
0.37
3.6
2.3
160.00
127.25
nmol/l
—
5
32
5
77
0.65
0.36
3.2
2.8
1.25
1.19
mmol/l
—
5
77
5
79
0.63
0.35
3.2
2.8
106.80
105.19
mmol/l
—
5
79
51
456
1.13
0.32
2.8
2.5
9.68
15.25
au/ml
—
5
48
10
131
0.76
0.31
1.7
1.6
85.06
55.89
ug/l
—
10
111
7
55
1.28
0.30
1.4
1.5
229.29
79.45
umol/l
—
7
55
7
56
1.25
0.29
1.3
1.4
—
—
—
0
0
33
288
1.15
0.29
13.2
4.5
23.95
24.82
mmol/l
1.08
33
272
28
241
1.17
0.29
1.5
1.7
352.43
283.47
mu/l
0.93
28
224
9
118
0.76
0.27
1.6
1.5
—
—
—
0
0
15
125
1.20
0.22
16.3
3.6
15.77
9.44
pmol/l
1.03
15
125
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
10.5
—
10.94
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
2.0
—
2.74
—
0
5
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
89
841
1.07
0.20
2.4
2.5
14.35
13.71
nmol/l
0.27
81
779
6
49
1.23
0.20
1.3
1.1
330.00
276.55
mg/l
—
6
42
6
51
1.18
0.19
1.3
1.1
—
—
—
0
0
10
81
1.24
0.19
1.2
1.3
—
—
—
0
0
9
82
1.10
0.15
1.1
1.1
—
—
—
0
0
26
285
0.91
0.14
7.5
3.6
1.01
1.02
ratio
3.00
20
270
37
346
1.07
0.12
1.7
1.9
51.46
37.20
nmol/l
1.41
37
337
35
374
0.93
0.12
3.8
3.6
4.34
4.63
pmol/l
1.09
30
332
5
47
1.06
0.09
1.4
1.1
—
—
—
0
0
17
155
1.10
0.09
1.3
1.2
3.81
3.69
mmol/l
0.17
17
147
5
65
0.77
0.08
1.2
1.1
—
—
—
0
0
6
75
0.80
0.07
1.2
1.1
—
—
—
0
0
15
163
0.92
0.07
2.3
1.9
5.47
4.21
iu/l
—
6
61
9
101
0.89
0.06
1.7
1.6
—
—
—
0
0
11
100
1.10
0.05
1.0
1.0
—
—
—
0
0
162
1608
1.01
0.02
2.7
3.0
0.77
0.71
ug/l
0.19
116
921
41
419
0.98
0.02
1.1
1.2
95.59
131.07
u/ml
—
7
171
14
145
0.96
0.00
1.1
1.6
—
—
—
0
0
34
341
1.00
0.00
1.1
1.0
—
—
—
0
0
7
70
1.00
0.00
4.3
2.8
19.71
19.53
nmol/l
—
7
64
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
2.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
50
1.00
-0.00
4.4
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
5.83
—
0
6
0
5
0.00
-0.00
0.0
5.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
6
59
1.02
-0.00
2.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_NEED_IMMUNI_OTH_SINGLE_VIRAL_DISEA – Need for immunization against other single viral diseases
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).